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 Erythrocytes are responsible for ensuring a sufficient supply of oxygen to meet 
activity demands. The mammalian erythrocytes primarily modulate their oxygen-
carrying capacity by varying the levels of organic phosphates, such as 2,3-BPG. In 
other organisms, such as fish, ATP instead of 2,3-BPG is used to modulate their 
erythrocyte’s oxygen binding ability. Here, using a series of genetically modified mice, 
we investigated a previously unrecognized pathway of adenine nucleotide influx and 
efflux that modulates erythrocyte’s oxygen binding ability and controls systemic 
metabolism. Our studies show that the loss of AMPD3 and CD73, two important 
enzymes in regulating AMP levels intra- and extra-cellularly, respectively, allows for an 
increase in sustained metabolic activity. We show that this increase in work capacity is 
linked to an increase in erythrocyte’s intracellular ATP levels which modulates 
hemoglobin affinity for oxygen directly. Pharmacologically, we show that Ampd3-/-
/Cd73-/- mice display an enhanced hypometabolic phenotype in response to AMP 
administration. Our studies reveal that the hypometabolism is associated with a severe 
reduction in oxygen binding affinity that results from erythrocyte’s uptake of AMP. 
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1. Introduction 
1.1. Metabolism and Metabolic Rate 
 An organism’s metabolic control is a key factor in ensuring survival; therefore, 
metabolism is highly regulated both on a systemic level and a cellular level to ensure 
optimal utilization of energy. The main regulation of systemic metabolism is believed to 
be controlled by the central nervous system, with a majority of this control coming from 
the peripheral signals interacting with the hypothalamus (Nasrallah and Horvath, 2014, 
Williams and Elmquist, 2012, Levin and Sherwin, 2011, Pocai et al., 2005). On the 
cellular level, there are numerous pathways (ex. AMPK, mTOR and PI3K/AKT, etc.) 
that are tightly regulated depending on the energy status and metabolic demand of the 
individual cell (Albert and Hall, 2014, Wullschleger et al., 2006, Gomes and Blenis 
2015). With these various levels of regulation, each individual maintains a basal 
metabolism or resting metabolic rate, which determines how quickly an individual uses 
energy supplies to sustain basic functions. For example, during exercise, muscle cells 
need two main components in order to maintain the high energy demand: more fuel 
substrates and more oxygen for the cells to increasingly produce more ATP (Felig and 
Wahren, 1975). This change in supply is mediated by a vascular signal to dilate the 
vessels upstream of the site of demand (Goldman et al., 2012). By contrast, during the 
basal metabolism, an individual can experience a drop in metabolic rate either 
transiently, such as during rest (Heldmaier et al., 2004), or for an extended period of 
time, as is the case in animals that undergo hibernation or daily torpor, two forms of 
hypometabolism observed in nature (Heldmaier and Ruf, 1992). 
1.2. Natural Hypometabolism 
2 
 
Natural hypometabolism is a physiological response that occurs in both endo- 
and ectotherms. However, since endotherms maintain their core body temperature at 
about 37°C, the energy demand of a similarly sized endotherm is at least eight times 
higher than that of an ectotherm (Else and Hulbert 1981). Hence under metabolic 
stress, the potential benefit an endotherm could receive from entering hypometabolism 
is significantly greater than for an ectotherm whose body readily adapts to ambient 
temperatures. As illustrated in Figure 1, deep hypometabolism has been observed in 
many different orders of mammals, including some primates. 
Among mammals, hypometabolism is generally classified into two categories, 
hibernation and daily torpor, based on the severity and length of hypometabolism 
(Heldmaier et al., 2004). Both hibernation and daily torpor are characterized by four 
stages (Figure 2): entrance, maintenance, arousal, and euthermia (Heldmaier et al., 
2004). Entrance is characterized by a sharp drop in metabolic rate that is followed by a 
gradual decline in core body temperature. Once the metabolic rate and body 
temperature have reached a nadir, the animal is considered to have entered the 
maintenance stage. The maintenance stage can last from many days to weeks for 
various cases of hibernation but only lasts hours for daily torpor. Typically, hibernators 
achieve greater drops in metabolic rate with lower core body temperatures than 
animals undergoing daily torpor (Geisner and Ruf 1995, Lovegrove et al., 1999, Wilz 
and Heldmaier 2000). In the maintenance phase, each animal species has an optimal 
range of ambient temperatures that allow for the most efficient metabolism during a 
hypometabolic bout (Figure 3). Lowering of Tb beyond optimal range can increase 
metabolic rate. At the end of the maintenance phase, the animals enter the arousal 
phase where a sharp rise in metabolic rate is followed by an 
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Figure 1. Daily torpor and/or hibernation among mammalian orders. Figure 
originally published by Heldmaier G, Ortmann S, Elvert R. 
Natural hypometabolism during hibernation and daily torpor in mammals. Respir 
Physiol Neurobiol. Aug 12;141(3):317-29 (2004) and reprinted with permission from 
Elsevier.  
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Figure 2. Variations in metabolic rate and body temperature (Tb) during 
hibernation in an Alpine marmot (A) and daily torpor in a Djungarian hamster  
(B). The four stages (entrance, maintenance, arousal, and euthermia) are labeled in A) 
and are clearly apparent in B). Figures originally published by Heldmaier G, Ortmann 
S, Elvert R. Natural hypometabolism during hibernation and daily torpor in mammals. 
Respir Physiol Neurobiol. Aug 12;141(3):317-29 (2004) and reprinted with permission 
from Elsevier. 
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Figure 3. Effect of environmental temperature on metabolic rate in a hibernating 
marmot showing a range of optimal hibernating temperature. Originally published 
by Heldmaier G, Ortmann S, Elvert R. Natural hypometabolism during hibernation and 
daily torpor in mammals. Respir Physiol Neurobiol. Aug 12;141(3):317-29 (2004) and 
reprinted with permission from Elsevier. 
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increase in core body temperature (Heldmaier et al., 2004). Upon returning to an 
euthermic temperature, the animal enters the fourth stage, euthermia, where the animal 
maintains normal euthermic functions either for a day or two (hibernators) or many 
hours (daily torpor) before beginning the next hypometabolic bout. These arousals from 
hibernation are very taxing on the energetic reserves of the animal; it has been 
estimated that ~70% of the energy used during a hibernation season is spent on the 
arousal and euthermic phases (Heldmaier et al., 1993). While the need for arousal can 
be eliminated when hibernators are kept at warm (>30°C) ambient temperatures 
(Dausmann et al., 2005), some investigators believe arousal is a necessary phase of a 
hibernation bout (Humphries et al., 2003, Carey et al., 2003). There are many 
hypotheses to explain these energetically costly arousal bouts: from a need to get REM 
sleep (Daan et al., 1991), to preventing damage to the central nervous system 
(Strijkstra et al., 2003), and replenishing depleted energy storage (glycogen) and some 
proteins of the mitochondrial electron transport chain (Carey et al., 2003).  
 It has been hypothesized that the initiation of a torpor bout is the result of a 
suppression of the metabolic rate, and that the drop of the core body temperature is a 
result of a change in the body’s thermostat set point, with no change in the organism’s 
thermoregulation (Heller et al., 1977). This active suppression of the metabolic rate is 
of particular interest as it was postulated to be the trigger for natural hypometabolism, 
but the underlying mechanism is unknown (Heldmaier et al., 2004). It has been 
proposed that metabolic suppression could be achieved via two mechanisms that are 
not mutually exclusive: a decrease in ATP creating processes and a down regulation of 
ATP consuming pathways (Heldmaier et al., 2004).  
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 There are examples of animals in hypometabolism of a shift in fuel utilization 
from carbohydrates to lipids (Andrews et al., 1998), of a general decrease in glycolysis 
and oxidative phosphorylation (Heldmaier et al., 1999, Martin et al., 1993), as well as 
decreases in gene transcription and protein translation (Heldmaier et al., 2004). This 
decrease in cellular processes would only account for ~30% of the reduced energy 
savings seen in hypometabolism (Buttgereit and Brand, 1995). Thus, it has been 
postulated that other, as yet unknown, mechanisms of energy saving are in play during 
hypometabolism. One hypothesis is that AMPK activation is a signal that coordinates 
the reductions in ATP consuming processes (Horman et al., 2005). AMPK is a 
conserved eukaryotic energy sensor that regulates ATP producing and utilizing 
pathways (Hardie et al., 1998). However, during hypometabolism AMPK activity 
increases in white adipose tissue but decreases in the liver (Horman et al., 2005), so a 
change in AMPK activity most likely does not cause the suppression of  metabolic rate 
that induces hypometabolism.  
1.3. Pharmacological Hypometabolism 
Natural hypometabolism is accompanied by reductions in heart rate, metabolic 
rate, breathing rate, and core body temperature (Heldmaier et al., 2004). Table 1 lists 
compounds currently known to induce hypometabolism, and thus could potentially be 
useful in treating heart attacks and stroke, surgeries, improving organ transplantation 
viability (Bouma et al., 2011). Currently, three molecules have been widely studied for 
pharmaceutically induced hypometabolism: hydrogen sulfide gas (H2S), 3-
iodothyronamine (T1AM), and 5’-adenosine monophosphate (AMP). 
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Table 1. Summary of known natural compounds that can be used to induce 
hypothermia in mice. Modified from Andrews MT. Advances in molecular 
biology of hibernation in mammals. Bioessays. May;29(5):431-40 (2007) and reprinted 
with permission from John Wiley and Sons. 
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H2S is produced naturally in the body in minute quantities as an antioxidant and 
anti-apoptotic signaling molecule (Gadalla and Snyder, 2010, Calvert et al., 2010). H2S 
is known to be a potent inhibitor of the electron transport chain (complex IV), which is 
thought to account for the observed reduction in metabolic rate, oxygen consumption, 
and the resulting reduction in core body temperature (Aslami et al., 2009, Blackstone, 
2005). However, an earlier study has demonstrated that inhaled H2S is rapidly taken up 
by erythrocytes, leading to an increased production of deoxygenated hemoglobin 
(Evans, 1967). It has been proposed that the primary effect of H2S poisoning is the 
disruption of the erythrocytes’ ability to transport oxygen (Evans, 1967). Studies using 
H2S in larger mammals (Bouma et al., 2011) consistently demonstrated anti-apoptotic 
effects but H2S did not induce hypometabolism, unlike the situation in small rodents. 
The mechanism underlying H2S induction of hypometabolism remains poorly 
understood. 
Another molecule of interest, T1AM, is produced naturally in the thyroid and has 
been shown to reduce metabolic rate when introduced exogenously (Braulke et al., 
2008). It is thought that T1AM is an agonist for the trace amine-associated receptor 
(TAAR1) (Panas et al., 2010). Compared to natural hypometabolism the duration of 
metabolic depression by T1AM is relatively short and the arousal phase is relatively 
prolonged (Braulke et al., 2008; Panas et al., 2010). Furthermore, the Tb drop induced 
by T1AM is relatively shallow, only several degrees below euthermia. The mechanisms 
of T1AM action leading to reduced Tb are not well understood.  
 The third molecule, AMP, has been shown to consistently induce 
hypometabolism in mice with a Tb maintained 1 or 2 °C above ambient temperature 
(Daniels et al., 2010). This study also demonstrated that AMP can induce 
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hypometabolism of dogs, suggesting a conserved pathway. Our previous studies 
implicated an interaction between AMP and erythrocytes in this process (Daniels et al., 
2010). Additional insights on the AMP induced hypometabolism will be discussed in the 
“Previous Studies” section. 
1.4. Oxygen Consumption/Delivery Control 
Metabolism and oxygen utilization have been intimately linked for almost a 
century, since scientists devised a model that suggested that the body needed tight 
coordination between the tissues that needed oxygen and the supply of oxygen 
delivered the oxygen sensing/delivery pathway (Krogh, 1919). Investigators have 
proposed and tested many hypotheses regarding a mechanism for such coordination. 
These ideas ranged from the endothelial cells themselves regulating the oxygen flow 
upon sensing tissue need (Pittman and Duling, 1973, Duling, 1974, Jackson, 1987), to 
signaling metabolites diffusing through the cells of the vessel walls (Hester 1993), to 
the smooth muscle around the endothelium being in control of the vasculature's 
response to surrounding signals (Ellworth et al., 1994, Ellworth and Pittman, 1990). 
Each theory had some supportive data; however, no scenario could completely explain 
the vascular response in regulating oxygen supply and demand. Studies have shown 
that the erythrocytes’ maintenance of oxygen supply was based on oxygen content 
(amount of oxygen molecules within the erythrocytes) and not oxygen tension 
(pressure of oxygen in the vasculature) as previously hypothesized (Jagger et al., 
2001). It was further hypothesized that the erythrocytes could be regulating oxygen 
supply and demand (Stein and Ellsworth 1993). Independent studies have found that 
erythrocytes release ATP, which can activate nearby purinergic receptors of activated 
endothelial cells releasing vasodilators, such as nitric oxide (NO) (Houston et al., 1987, 
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Motte et al., 1993, Kennedy et al., 1985). Given the abundance of nucleotidases in 
circulation, it was postulated that the ATP target must be extremely close to the ATP 
release site (Meghji et al., 1995). If the erythrocytes are the source of the extracellular 
ATP, it appeared logical that this ATP release mainly occurs in the capillaries, where 
erythrocytes change shape as they pass through the narrow capillaries (Pries et al., 
1996). To examine the feasibility of this mechanism, it was shown that the amount of 
ATP released by the erythrocytes quickly causes vasodilation prior to the site of ATP 
release (Sprague et al., 2007, Bergfeld and Forrester 1992). Other studies have 
demonstrated that the ATP signal not only results in the endothelial cells increasing the 
oxygen tension for surrounding tissues, but it also increases the diameter of the 
vessels, allowing for an increase in the number of erythrocytes that can flow to the area 
(Ellsworth, 2000). These studies have supported the hypothesized role of the 
erythrocyte as the cellular mediator that senses the local demand for oxygen and 
increases local oxygen delivery.  
1.5. Hemoglobin 
Hemoglobin, the predominant protein in erythrocytes, is responsible for the 
characteristic red color of erythrocytes, and determines the erythrocytes' interactions 
with oxygen and other gas ligands (e.g., CO2, NO, CO, and H2S). On one level, the 
body controls the amount of oxygen that can be delivered to the peripheral organs by 
regulating the number of erythrocytes that are created (erythropoiesis) and destroyed 
(eryptosis) (Lang et al., 2012). This balance is tightly regulated; too few erythrocytes in 
circulation can cause anemia, too many and the blood becomes viscous, which can 
lead to seizures, heart attacks, or thrombosis (Jelkmann, 2012).  
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Beyond the number of erythrocytes, the hemoglobin within erythrocytes is the 
major regulator of oxygen availability. Hemoglobin is a tetramer of two alpha and two 
beta globins, each containing a heme group that binds oxygen (Adair 1925). These four 
binding pockets exhibit cooperative behavior and investigators have devised binding 
models to explain the sigmoidal shape of hemoglobin's oxygen binding curve (Yonetani 
and Kanaori, 2013). The binding pocket of each heme group can either be oxygen-
bound (relaxed or R state) or deoxygenated (tense or T state) (Yonetani and Kanaori, 
2013). It had long been expected that the change from the R to T state was due to a 
change in the structure of the binding pocket because modulators affecting oxygen 
affinity were only thought to bind to the T state (Perutz, 1970, Yonetani and Kanaori, 
2013). However it has been found recently that modulators, or allosteric effectors, are 
able to bind to both the R and T states (Yonetani and Kanaori, 2013). They also 
showed that the oxygen affinity parameters (p50, Klow, etc.) of hemoglobin did not 
change between the T and R states. Rather, the adjustment of these parameters for a 
given binding state is through the binding of allosteric effectors, which do not alter the 
quaternary or tertiary structure of the hemoglobin (Yonetani and Kanaori, 2013). These 
effectors are organic phosphates, chloride ions, hydrogen ions (Bohr effect), and 
temperature (Weber and Campbell, 2011). Whereas temperature is a global effector, 
the three molecular effectors work by binding to various, specific sites on hemoglobin: 
organic phosphates bind to the beta chain at one of four amino acid sites (residues: 1, 
2, 82 and 143); chloride ions bind in a general area on either alpha or beta chains, and 
hydrogen ions bind solely to amino acid position 146 on the beta chain (Weber and 
Campbell, 2011). The binding of these effectors has a diverse set of effects, which is 
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the basis for physiological modulation of hemoglobin’s oxygen transport abilities 
(Yonetani and Kanaori, 2013). 
Knowing that the effectors are changing oxygen affinity but are not altering the 
protein structure, the obvious question that follows is: how do the modulators affect the 
oxygen affinity? It was discovered that effectors alter residues on the distal side of the 
heme binding pocket, which generates “dynamic fluctuations” (Kanaori et al., 2011). It 
had been recently proposed that these dynamic fluctuations would alter the ease of gas 
ligand (O2, CO2, NO) escape from the ligand-hemoglobin complex (Yonetani and 
Kanaori, 2013). As illustrated in Figure 4, this working model states that different 
effectors alter the gating of hemoglobin, allowing the ligand to leave at different rates 
due to a regulation of the thermal fluctuations. For instance, it has been shown that 2,3-
BPG, an organic phosphate allosteric effector of hemoglobin, acts by increasing the 
rate of dissociation of oxygen, which would increase its ability to completely separate 
from the heme pocket (Salhany et al., 1970). It has also been shown that the reason T 
state hemoglobin is deoxygenated is the greater thermal fluctuation in that state 
allowing the ligands to more readily escape compared to the R state (Kanaori et al., 
2011).  
Some investigators sought to understand the differences among animals in their 
responses to the same effectors. For instance, fish hemoglobin is influenced by the 
binding of ATP rather than binding 2,3-BPG as in mammals (Weber and Campbell, 
2011). These various animals’ hemoglobin structures have been evaluated and the 
resulting alterations shed light on to the differential impact effectors have on particular 
hemoglobins (Weber and Campbell 2011). Some have changes in amino acid residues 
affect its affinity for organic phosphates (Weber and Campbell, 2011). Others have a 
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Figure 4. Ligand-hemoglobin binding steps as postulated by Yonetani and 
Kanaori, 2013. This schematic depicts two additional forms of hemoglobin (caged-2 
and caged) between the oxygen-bound (oxy) and the oxygen-free (deoxy) states, with 
effectors (such as ATP and 2,3-BPG) modulating the central equilibrium. Figure 
adapted from Yonetani T, Kanaori K. How does hemoglobin generate such diverse 
functionality of physiological relevance? Biochim Biophys Acta. Sep;1834(9):1873-84 
(2013) and reprinted with permission from Elsevier. 
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synergistic effect between the binding of the chloride ions and the organic phosphate 
molecules (Colletta et al., 1994). These genetic variations have shed light on how 
hemoglobin can operate differently in various species. 
Regardless the animal species that hemoglobin is operating in, its major role is 
the same: it carries oxygen to tissues and removes carbon dioxide from them. 
1.6. Adenine Nucleotide Pathways 
So far, we have described what is known about the regulation of systemic 
metabolism, oxygen delivery, and the role played by the erythrocytes and hemoglobin. 
We now turn to the modulation of erythrocytes’ functions by adenine nucleotides.  
The absolute and relative intracellular levels of various adenine nucleotides have 
long been thought to be central to control of carbohydrate metabolism (Hunter and 
Jefferson, 1969). The levels of ATP, ADP, and AMP are all tightly regulated, inside and 
outside of the cell (Dzeja and Terzic, 2009). One way this regulation is achieved is 
through the cell membrane. Due to the negative charge of nucleotides, their ability to 
passively diffuse across the membrane is extremely limited. For example, an early 
study (Liebman and Heidelberger, 1955) found that AMP must be degraded to 
adenosine before being taken up into hepatocytes through the equilibrative nucleoside 
transporters (ENTs) and subsequently rephosphorylated back into AMP. Once in the 
cells, AMP has been shown to allosterically modify metabolic enzymes, inhibit 
nucleotide biosynthesis (Stadtman, 1966) and increase TCA cycle intermediate 
turnover (Hunter and Jefferson, 1969).  
Both extracellular and intracellular levels of adenine nucleotides are tightly 
regulated by several well studied enzymes. There is an extracellular ATPase (CD39) 
that converts ATP to ADP and then AMP (Wang and Guidotti, 1996). In addition, an 
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extracellular ectonucleotidase (CD73) dephosphorylates AMP to adenosine (Thompson 
et al., 1990). Adenosine is taken up through nucleoside transporters such as ENT1/2, 
and intracellular adenosine can be phosphorylated by adenosine kinase, forming AMP 
(Liebman and Heidelberger, 1955). Adenosine is quickly deaminated to inosine by 
adenosine deaminase (ADA) (Schaedel et al., 1947).  AMP can be phosphorylated by 
adenylate kinase (AK) (with ATP as phosphate donor) to produce ADP (Dzeja and 
Terzic, 2009). Another fate of intracellular AMP is deamination to inosine 
monophosphate (IMP) (Hancock et al., 2006). In nucleated cells, IMP can be converted 
back to AMP by adenylosuccinate synthase and lyase (Hancock et al., 2006).  
 Unlike nucleated cells, erythrocytes do not carry out de novo purine biosynthesis 
nor do they have a salvage pathway for IMP. Despite having a regulatory environment 
for extracellular adenine nucleotides similar to other cell types, erythrocytes seem to 
have a distinct mechanism to take up extracellular AMP efficiently (Daniels et al., 2010; 
Mathews et al., 2005). Erythrocyte AMP is mainly catabolized through AMP deaminase 
3 (AMPD3), an irreversible reaction due to the erythrocyte's lack of adenylosuccinate 
synthase and lyase (Baranowska-Bosiacka et al., 2004).  
Several nucleotide transporters have been found in the erythrocyte membrane, 
such as Pannexin (Goldman et al., 2012). Pannexin channels have been proposed to 
release ATP from erythrocytes in response to decreased oxygen saturation (Goldman 
et al., 2012).  
Interestingly, recent studies of the erythrocyte membrane have found both ANT 
(ATP/ADP translocase) and VDAC (voltage dependent anion channel) (Bouyer et al., 
2011). The erythrocytes’ release of ATP could be blunted by TRO19622, a specific 
VDAC inhibitor (Sridharan et al., 2012). ANT belongs to the SLC25 family; most 
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members of this family are antiporters that can be inhibited to varying degrees by 
carboxyatractyloside (CAT), bongrekic acid (BA), and tannic acid (TAN) (Guitierrez-
Aguilar and Baines, 2013). VDAC facilitates passive diffusion of many different 
molecules, regardless of size or charge (Shoshan-Barmatz et al., 2010). VDAC can be 
modulated by calcium and by adenine nucleotides, as well as by 4,4’-
diisothiiocyanostilbene-2-2’-disulfonic acid (DIDS) (Shoshan-Barmatz et al., 2010). 
1.7. Previous studies 
Our earlier investigations identified AMP as a biomolecule that can induce 
hypometabolism in mammals (Daniels et al., 2010). We demonstrated the length of 
AIHM is not dosage dependent. Induction of AIHM is specific to adenine among the 
nucleotides (Daniels et al., 2010). We and others have shown that AMP induced 
hypometabolism (AIHM) mimics some of the features observed in natural hibernation. 
Our observation that circadian control of gene expression during AIHM is largely stalled 
was also observed in hamsters during natural hibernation (Zhao et al., 2011, Revel et 
al., 2007). Others have shown that lymphopenia observed in natural hibernators is also 
observed in mice during AIHM (Bouma et al., 2013). While there are similarities 
between AIHM and natural torpor, there are also dissimilarities. One of the 
dissimilarities is that the rate of Tb reduction observed in natural torpor is typically 
slower than that in AIHM (Strijkstra et al., 2012).  
AMP administration leads to rapid slowing of the heart rate, and it has been 
suggested that adenosine receptor (A1a) mediated bradycardia was the underlying 
mechanism for AIHM (Swoap et al., 2007). However, we observed that wild type, A1a-/-, 
A2a-/-, A2b-/-, and A3a-/- mice undergo AIHM in a similar fashion (Daniels et al., 2010), 
demonstrating that the disruption of adenosine receptor function did not alter AIHM. 
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Interestingly the rapid decline in heart rate in response to AMP seen in wildtype mice 
was absent in A1a-/- mice, suggesting bradycardia is not the cause, but a result of 
AIHM (Tao et al., 2011). We further investigated if adenosine is needed for the AIHM 
response by studying the impact of eliminating CD73, the ecto-nucleotidase 
responsible for dephosphorylating AMP to adenosine extracellularly (Zhang 2010), on 
AIHM. We observed that Cd73-/- mice were more sensitive to lower doses of AMP than 
wildtype mice (Daniels et al., 2010), suggesting that the deficiency of this nucleotidase 
enhanced the effect of injected AMP. This finding demonstrated that generation of 
adenosine via dephosphorylation of AMP by CD73 actually impeded AIHM.  
Using radioisotope tracing, we observed that AMP was rapidly taken up into 
erythrocytes (Daniels et al., 2010). This finding was consistent with an earlier 
observation that identified erythrocytes as a major cellular target of AMP in a whole 
body study with radiolabelled AMP (Mathews et al., 2005). Corresponding to AMP 
uptake, The kinetics of increasing erythrocyte levels of 2,3-BPG, the main hemoglobin 
modulator, paralleled those of AMP uptake following an AMP injection (Daniels et al., 
2010). Serum 2,3-BPG was also significantly elevated during AIHM (Zhao et al., 2014). 
Given that 2,3-BPG mutase, the key enzyme for 2,3-BPG biosynthesis, is only found in 
erythrocytes and placenta (Pritlove et al., 2006), these results implicate erythrocytes as 
the cellular target of AMP (Daniels et al, 2010).  
To further characterize the role of the erythrocytes in AIHM, we investigated the 
effect of altering AMP degradation within erythrocytes. There are two pathways for 
AMP catabolism: dephosphorylation to adenosine and subsequent conversion to 
inosine via ADA; and deamination of AMP to inosine monophosphate (IMP) (Figure 5). 
Given that the Km of ADA for adenosine is two orders of magnitude larger than that of  
19 
 
 
 
 
 
 
 
 
 
Figure 5. Km values of various enzymes relating to intracellular catabolism of 
AMP in erythrocytes.  
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adenosine kinase, we reasoned that the majority of AMP catabolism must be via its 
deamination to IMP. Since erythrocytes do not have a salvage pathway for converting 
IMP back to AMP (Baranowska-Bosiacka et al., 2004), the catabolism of AMP by AMP 
deaminase (AMPD) would be irreversible. We sought to disrupt AMP degradation in 
erythrocytes by mutating the gene for AMPD3, the enzyme isoform responsible for 
AMP deamination in erythrocytes (Daniels et al., 2013). Thus, we created a strain of 
mouse deficient in AMPD3, the AMPD3-/- model. We expected that elimination of this 
pathway would drastically increase intracellular AMP levels. However, we observed 
that erythrocyte AMP levels did not change significantly in the AMPD3-/- model (Daniels 
et al., 2013). Instead, both ATP and ADP levels increased about 3-fold. Additionally, we 
observed that Ampd3-/- mice, like the Cd73-/- mice, were more prone to AIHM than wild 
type mice. These results with single knockout models indicated that CD73 and AMPD3 
each modulate AIHM, and they further indicate that erythrocytes have a major role in 
mediating AIHM. These observations led to several important questions that are central 
to my thesis studies:  
 1. What is the physiological importance of CD73 and AMPD3 to mammalian 
metabolism?  
 2. Does alteration of AMP catabolism affect the physiological functions of 
erythrocytes, particularly oxygen transport?  
 3. Can CD73 and AMPD3 deficiency models help elucidate the mechanism of 
AIHM?  
 4. How is the erythrocytes’ oxygen transport affected when exposed to non-
physiological levels of AMP, such as in AIHM?  
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 5. In contrast to nucleated cells, erythrocytes are capable of AMP uptake. Is 
there a functional significance of this capability? 
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2. Materials & Methods  
Materials: Radiolabelled nucleotides were acquired from Moravek Biochemicals. 
Solutions for the Hemox-Analyzer were acquired from TCS Scientific Corporation. 
Phosphate Buffered Saline (BP399-1, 10X PBS solution diluted to 1X prior to use with 
final concentrations of 11.9 mM Phosphates, 137 mM Sodium Chloride, and 2.7 mM 
Potassium Chloride) was acquired from Fisher Scientific. TRO19622 was acquired from 
Tocris Bioscience (Bristol, United Kingdom). All other chemicals and reagents were 
acquired from Sigma.  
Mouse housing/husbandry/protocols: All animal studies were carried out in the 
institutional animal facility by trained personnel under protocols HSC-AWC-13-012 and 
HSC-AWC-12-079 approved by the Animal Welfare Committee (AWC), the institutional 
animal care and use committee (IACUC) at UTHSC-Houston. Wild type mice were 
ordered from Jackson Laboratory (Bar Harbor, Maine). The Cd73-/- mice were obtained 
from Dr. L. Thompson (Thompson et al., 2004). The Ampd3-/- mice were generated as 
previously reported (Daniels et al., 2013). The Cd73-/-/Ampd3-/- mouse was generated 
from breeding the Cd73-/- with the Ampd3-/-, followed by backcrossing the F1. Mice 
were maintained in the animal facilities with a 12h:12h light:dark cycle at an ambient 
temperature of ~23°C. Mice had access to standard rodent chow and water ad libitum 
and their cages were changed twice a week. 
Wheel running experiments: Mice were placed in individual cages with a running 
wheel within a circadian chamber and provided with food and water ad libitum as 
previously described (Miki et al., 2013, Siepka and Takahashi, 2005). Briefly, wheel-
running activity was measured continuously using Actiview Software. For each 
genotype, both male and female mice (n=4) of similar age (14-18 weeks) were used. 
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Mice were kept in a 12h:12h light:dark (LD) cycle for 2 weeks. The quantification of 
total wheel revolutions in zeitgeber time (ZT) was determined using Actiview software. 
Metabolic chamber experiments: A Comprehensive Lab Animal Monitoring 
System (CLAMS, Columbus Instruments, Columbus, OH) was used to measure animal 
metabolic rate as previously described (Daniels et al., 2010). Briefly, each chamber 
contained an individual mouse with free access to food and water. The O2 consumption 
and CO2 production of each mouse were monitored and recorded with the OxyMax 
System from Columbus Instruments. Each chamber has the option of wheel addition for 
running. The chamber was maintained at normal husbandry conditions at 23°C under a 
12h:12h LD cycle.  
Erythrocyte isolation: Whole blood was collected from a tail clip and allowed to 
drip into a heparinized Eppendorf tube. The whole blood was then centrifuged at 4°C at 
3000 rpm for one minute. The plasma was then removed and the erythrocytes were 
washed 3X by resuspension in a 10X volume of ice-cold phosphate buffered saline 
(PBS) and centrifugation was repeated. After a final wash, the resulting erythrocyte 
pellet was resuspended with a small volume of PBS to about the original whole blood 
volume. The resulting suspension was counted on a hemacytometer for the number of 
erythrocytes after two serial 1:100 dilutions. Based on the cell count, the isolated 
erythrocytes were then diluted with PBS to obtain about 106 cells/µL. For oxygen 
saturation experiments, TLC experiments, AMP uptake experiments, and ATP release 
experiments, 10 µL of 106 cells/µL were used; for adenine nucleotide extraction 
experiments, 75 µL of 106 cells/µL were used. Erythrocytes from mice of all the 
genotypes were prepared in a similar manner.  
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Blood Oxygen Saturation experiments: All blood oxygen saturation experiments 
were measured with a Hemox Analyzer from TCS Scientific Corporation as described 
by Guarnone et al. (1995). Solutions for the Hemox Analyzer were also acquired from 
TCS Scientific Corporation. Briefly, 10 µL of 106/µL of erythrocytes were incubated in 4 
mL of Hemox buffer, 10 µL anti-foaming agent (AFA-25, TCS Scientific Corporation) 
and 0.1% BSA and equilibrated at 37°C. In experiments where lysate was used, the 10 
µL of 106/µL of erythrocytes were treated by freeze-thawing twice to generate the 
lysate. Once the sample in the Hemox Analyzer had equilibrated to a pO2 of 150 mmHg 
and a temperature >36.7°C, measurement of oxygen saturation was initiated by 
perfusing the sample with nitrogen gas to deoxygenate the hemoglobin. The analysis of 
p50 was complete once the pO2 was below 2 mmHg. 
2,3-BPG Quantification: The quantification of erythrocytes’ 2,3-BPG was carried 
out as described by Rumi et al. (2009). Briefly, erythrocytes were isolated as described 
above and then, as per the kit manufacturer’s instructions, they were neutralized and 
processed to quantify the amount of 2,3-BPG in the sample (Roche Lifescience). In 
parallel, the concentration of erythrocyte protein was quantified using a BCA Assay kit 
(Pierce). The level of 2,3-BPG was then normalized to the level of total protein.  
Adenine Nucleotides Measurements: Adenine nucleotide measurements were 
carried out as described by Stocchi et al. (1985). Briefly, 2 volumes of 7.5% perchloric 
acid were added to isolated erythrocytes, mixed by vortexing, and then centrifuged for 
10 min at 4°C at 13,000g. The supernatant was neutralized with an equal volume of 
0.75 M K2CO3. After neutralization, the reaction mixture was centrifuged at 4
°C for 10 
min at 13,000 x g and the resulting supernatant was injected on a pre-equilibrated 
HPLC C-18 column. The HPLC elution gradient was as described by Bhatt et al. 
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(2012). Buffer A: 30 mM KH2PO4 + 0.8 mM TBAP (tetrabutylammonium phosphate) pH 
5.45. Buffer B: 50% (v/v) acetonitrile in 30 mM KH2PO4 + 0.8 mM TBAP, pH 7.0. After 
each run, a 20 minute flush with Buffer A was carried out to re-equilibrate the column.  
Preparation of Hemoglobin: Lyophilized human Hemoglobin (Sigma #H7379) 
was dissolved in 50 mM HEPES buffer, pH 7.4 (final concentration of Hb was 
calculated to be about 2mM in a volume of 0.5mL) and reduced with powder of  sodium 
hydrosulfite (3-5 crystals) (Sigma #157953). Reduced hemoglobin was passed through 
an Econo-Pac 10 DG Desalting column (Bio-Rad), pre-equilibrated with aerobic 
HEPES buffer, to remove excess sodium hydrosulfite and form oxyhemoglobin. 
Electronic absorption spectra of oxyhemoglobin were recorded using a Hewlett-
Packard 8452A diode-array spectrophotometer. The concentration of oxyhemoglobin 
was calculated using an extinction coefficient of 128 (mM heme)-1cm-1 at 415 nm 
(Antonini and Brunori, 1971). 
Injection of AMP in mice: Mice were fasted overnight and an intraperitoneal 
injection with the desired dose of 5’-AMP in sterile saline was given early in the 
morning to induce the 5’-AMP Induced Deep Hypometabolic (AIHM) state. The 
metabolic chamber is maintained at ~15°C during these experiments in order to 
facilitate the induction and maintenance of the AIHM state. The animals were 
monitored via the CLAMS computer readout and were removed from the metabolic 
chamber and placed in their room temperature cage upon arousal from the AIHM state. 
We defined the AIHM state as a VO2 below 1200 mL/kg/h. We have observed that 
most mice would begin arousal and rapid re-warming not long after reaching a VO2 of 
1500 mL/kg/h.  
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Incubation of erythrocytes with adenosine/AMP/other nucleotides: Adenosine 
(Ado) was dissolved in DMSO to make a stock of 200mM, which was then diluted to the 
appropriate concentration with PBS. Solutions of the other nucleotides were prepared 
similarly. After addition of nucleotide, the erythrocyte suspension was shaken at 37°C 
at 750 rpm in a thermomixer. At the desired time, the erythrocytes suspension was 
removed and processed according to the experimental protocol.  
TLC of Radiolabelled ADP/AMP: Isolated erythrocytes (13 µL cells) were 
incubated at 37°C with 2 µL of stock [14C]-AMP or [14C]-ADP for the desired time and 
then centrifuged at 4°C for 1 min at 3000g to separate cells from supernatant. The 
supernatant was removed and saved for future analysis. The cell pellet was washed 
twice with 1 ml of cold PBS, and the final cell pellet was lysed by mixing rapidly with 15 
µL of 5% TCA. The reaction mixture was centrifuge, and final supernatant saved for 
TLC analysis. Both the initial supernatant and the final supernatant were then spotted 
(1 µL at a time, with a hairdryer used to speed up drying) on plastic TLC plates coated 
with silica gel 60 and F254 fluor (Merck). The TLC plates were developed with butanol / 
methanol / water / ammonium hydroxide (60:20:20:1). The TLC plate was then air dried 
and the radioactive bands visualized by exposure to X-ray film at -80°C. 
Uptake of AMP using 14C-AMP: Isolated erythrocytes were incubated at 37oC 
with various concentrations of AMP with constant specific activity. After 45 min 
incubation at 37oC, all reactions were centrifuged to separate cells from supernatant. 
The supernatant was removed and kept for further analysis. The cell fraction was 
washed twice with 1 ml cold PBS, and the final cell pellet was lysed by mixing with 15 
µL of 5% TCA. The amount of radioactivity in the supernatant and cell fractions were 
determined by adding 10 mL of ScentiSafe Econo 2 scintillation cocktail (Fisher) and 
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vials were counted for 5 min each using a scintillation machine [Pharmacia Rackbeta 
#1209-015]. In experiments where an inhibitor was used, the inhibitor was pre-
incubated with the erythrocytes for 5 minutes prior to addition of AMP. In competition 
experiments with other nucleotides/metabolites, each competitor was added at the 
same time as AMP.  
ATP release: ATP released by erythrocytes was measured using a Perkin Elmer 
ATP luciferase kit following the manufacturer’s instruction. Initial experiments were 
recorded using a 96-well plate luminometer [Envision Multilabel Reader (Perkin Elmer) 
#2104-0010] in real time. In the experiments with inhibitors, the erythrocytes were 
preincubated with inhibitor for 5 minutes before addition of AMP.  
Statistics: All values plotted are averages +/- SEM, with the significance of any 
differences evaluated by either t-test or ANOVA, as appropriate for the data set.  
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3. CD73 and AMPD3 deficiency enhance metabolic performance via erythrocyte 
ATP that decreases hemoglobin oxygen affinity 
3.1. Results 
3.1.1. Mice deficient in CD73 and AMPD3 display enhanced levels of locomotor 
and metabolic activities.  
The Ampd3-/-/Cd73-/- mice are fertile and morphologically indistinguishable from 
wild type mice. In an effort to find possible physiological differences in Ampd3-/-/Cd73-/- 
mice, we measured their locomotor activity assessed by wheel-running measurements 
using age and sex matched wild type, Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- mice. The 
wheel running results revealed that the Ampd3-/-/Cd73-/- mice had enhanced levels of 
locomotor activity compared with wild type, Ampd3-/- or Cd73-/- cohorts (Figure 6 A and 
B). The actograms revealed that wheel running activities for Ampd3-/-/Cd73-/- mice 
appeared largely continuous during zeitgeber time (ZT) 12-24, unlike the other 
genotypes, where periods of activity were interrupted by periods of rest. The wheel-
running activity between ZT0-ZT12 was low and similar among the four genotypes, 
indicating that their activities were under circadian regulation. The average daily wheel 
running activity of an Ampd3-/-/Cd73-/- mouse was about three-fold higher than for a 
wild type mouse. The average wheel running activity of an average Ampd3-/- mouse 
was moderately, but significantly, elevated compared to wild type. Daily locomotor 
activity of an average Cd73-/- mouse was not significantly different from wild type. 
Comparing Ampd3-/-/Cd73-/- to Ampd3-/- mice shows the latter had significantly less 
locomotor activity, suggesting that CD73 and AMPD3 are likely additive in regulating 
the AMP degradation pathway.  
Next, we measured metabolic rate based on oxygen consumption (VO2) of mice  
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Figure 6. Locomotor activities of wild type, Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- 
mice. A) Representative individual wheel running actograms of the four genotypes of 
mice in a 12:12h Light:Dark (LD) cycle. B) The average wheel running activities 
between ZT12-ZT24 for the wild type, Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- mice 
(n=4). P values = * < .05, # < .01, ** < .005, and *** < .0001. 
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in the presence and absence of running wheels. When a running wheel was not 
accessible, the metabolic rates of Ampd3-/-/Cd73-/- and wild type mice were comparable 
(Figure 7 A). When a running wheel was provided, both wild type and Ampd3-/-/Cd73-/- 
mice displayed enhanced metabolic activities. However, the Ampd3-/-/Cd73-/- mice 
exhibited significantly elevated average daily VO2 when compared to wild type (Figure 7 
A and B). Providing access to a wheel for Cd73-/- or Ampd3-/- mice did not significantly 
enhance their average daily VO2 levels over wild type (Figure 7 B, D, and E). We 
further undertook measurement of daily food consumption among the genotypes with 
access to wheel running. These measurements indicate that the Ampd3-/-/Cd73-/- mice 
ate significantly more than Ampd3-/-, Cd73-/-, or wild type mice when access to wheel 
running was provided (Figure 7 C). Thus, the metabolic activities of the mice appear to 
correlate in part with food intake. Together, these observations suggest that loss of 
AMPD3 and CD73 function has a additive impact on the capacity for metabolic activity 
and food consumption in mice. 
3.1.2. Loss of AMPD3 alters erythrocyte oxygen saturation level.  
We suspected that the observed continuous metabolic activity phenotype of 
Ampd3-/-/Cd73-/- mice (Figure 6) could be linked to changes in the erythrocytes’ main 
function of oxygen transport. Using a Hemox analyzer, we measured the pressure 
required for 50% oxygen saturation (p50) in isolated erythrocytes from wild type, 
Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- mice. Strikingly, the p50 value was significantly 
increased in Ampd3-/- erythrocytes, by 4 to 6 mmHg, when compared to erythrocytes 
from wild type mice (Figure 8 A and B). Relative to wild type, the p50 was also 
increased by 5 to 9 mmHg in Ampd3-/-/Cd73-/- erythrocytes. The p50 values obtained 
for erythrocytes from Cd73-/- mice were not significantly different from wild type mice.  
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Figure 7. Loss of both CD73 and AMPD3 affects locomotor and metabolic 
activities of mice. A), B) and C) Representative oxygen consumption (VO2) readings 
of a wild type and Ampd3-/-/Cd73-/- (A) Ampd3-/- (B) or Cd73-/- (C) mouse without and 
with access to an exercise wheel. D). The daily average metabolic activity with access 
to a wheel for wild type, Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- (n=4/genotype) mice 
over a period of seven days. E) The daily food consumption by the mice in D). P values 
= ## < .0005, and *** < .0001. 
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Figure 8. Erythrocytes’ p50 and 2,3-BPG values in mice deficient in AMPD3 
and/or CD73. A) Representative profiles of oxygen saturation vs oxygen pressure of 
isolated erythrocytes from wild type, Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- mice. B) 
Quantitative change in isolated erythrocytes from Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-
/- p50 value with respect to wild type erythrocytes. C) Erythrocyte 2,3-BPG levels in wild 
type, Ampd3-/-, Cd73-/-, and Ampd3-/-/Cd73-/- mice. Each plotted point represents an 
individual mouse. P values = *** < .0001 
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The right shift of the p50 value indicates that a higher pressure is required for the 
erythrocytes to reach 50% oxygen saturation. These data indicate that the erythrocyte’s 
affinity for oxygen is reduced, facilitating the release of oxygen to tissues.  
Since 2,3-BPG is known as the main intracellular modulator of Hb’s affinity for 
oxygen (Mulquiney and Kuchel, 1999), and an increase in its concentration shifts the 
Hb oxygen dissociation curve rightward (Isaacks et al., 1987), we measured 2,3-BPG 
levels in erythrocytes from all four genotypes. We found no significant difference in 2,3-
BPG levels among the erythrocytes of the different genotypes (Figure 8 C). These 
findings indicate that the increase in p50 value is not due to a rise in intracellular 2,3-
BPG levels.  
Next we investigated whether a genotype-specific change in erythrocyte pH was 
involved. Erythrocytes from each of the genotypes in Hemox reaction medium all had 
an extracellular pH of 7.4, the same as the medium’s pH. To measure the erythrocytes’ 
intracellular pH, 100 µL samples of isolated erythrocytes from each genotype were 
lysed in 0.5 mL of deionized water, and the pH of these lysates was measured at 37°C. 
The erythrocyte’s intracellular pH value was 7.2 for wild type mice, and 7.3 for Ampd3-/-
, Cd73-/-, and Ampd3-/-/Cd73-/- mice. The values measured were consistent with the 
physiological pH range of the erythrocyte’s cytosol, between pH 7.1-7.3 (Funder and 
Wieth, 1966). Since the p50 measurements were carried out at 37°C, the effects of 
temperature on Hb affinity for oxygen could be excluded. Together, it appears that mice 
deficient in AMPD3 have an elevated erythrocyte p50 value that is not linked to an 
increase in intracellular 2,3-BPG levels or to a change in intracellular pH.  
3.1.3. Elevated adenine nucleotide levels in AMPD3 deficient erythrocytes.  
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We reasoned that in Ampd3-/-/Cd73-/- mice, the blockade of AMP catabolism in 
erythrocytes could alter the levels of ATP and ADP, as well as AMP, since ATP and 
ADP must first be dephosphorylated to AMP before they can be further catabolized 
(Ataullakhanov and Vitvitsky, 2002). Utilizing HPLC, we measured the levels of adenine 
nucleotides after perchloric acid extraction of erythrocytes from the four genotypes 
(Figure 9 A-C). The data showed that total adenine nucleotides were significantly 
increased in Ampd3-/- erythrocytes, largely due to increases in ATP and ADP rather 
than AMP. AMP levels in Ampd3-/- erythrocytes are about two-fold higher than those in 
Ampd3+/+ erythrocytes. By contrast, ADP and ATP levels were about three-fold 
increased in Ampd3-/- erythrocytes compared with Ampd3+/+ erythrocytes. Consistent 
with previous reports, and irrespective of the mouse genotype, we observed that the 
ratios of [ATP] to [ADP] and [ATP] to [AMP] were maintained at approximately 10:1 and 
100:1, respectively (Benesch and Benesch, 1967, Formato et al., 1990).  
ATP comprises the majority of the erythrocyte adenine nucleotide pool in all 
genotypes of mouse (Figure 9). Comparison of Ampd3-/-/Cd73-/- to Ampd3-/- 
erythrocytes showed that ATP and ADP, but not AMP, were significantly elevated. 
Relative to wild type erythrocytes, the ATP levels of Ampd3-/-/Cd73-/- and Ampd3-/- 
erythrocytes showed an average increase of 3.2- and 2.8-fold, respectively (Fig 9 B 
and C). These findings suggest that AMPD3 is the major regulator of the erythrocyte 
adenine nucleotides pool. 
Interestingly, the different adenine nucleotides levels in erythrocytes among the 
four genotypes (Figure 9) correlate well with their erythrocyte p50 values (Figure 8). 
This correlation suggests that the observed increase in the Ampd3-/- erythrocyte’s p50 
values are associated with the increased cellular adenine nucleotide levels. 
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Figure 9. Erythrocyte adenine 
nucleotide levels in wild type, 
Ampd3-/-, Cd73-/-, and Ampd3-/-
/Cd73-/- mice. Mouse erythrocytes 
were analyzed for the levels of: A) 5’-
AMP, B) ADP and C) ATP. Each 
plotted point is an individual mouse. 
P values = * < .05, # < .01, ** < .005, 
and *** < .0001. 
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3.1.4. Modulation of hemoglobin’s oxygen saturation by ATP. 
Previous studies have demonstrated that many organic phosphates can bind to 
Hb and modulate its affinity for oxygen (Benesch and Benesch, 1967). However, it has 
been proposed that, except for 2,3-BPG, the physiological concentrations of the 
majority of these organic phosphates are too low to be effective in vivo moderators of 
Hb affinity for oxygen (Benesch et al., 1968). 
In Ampd3-/-/Cd73-/- mice, the endogenous erythrocyte adenine nucleotide levels 
are ~3-fold higher than those in wild type mice. Therefore, we investigated whether 
these increased levels of adenine nucleotides are sufficient to alter Hb’s affinity for 
oxygen and thus account for the increase in p50 values. The physiological intracellular 
concentration of ATP in wild type erythrocytes is estimated to be between 1-2.5 mM, 
ADP at 0.1-0.25 mM, and AMP at 0.01-0.02 mM (Benesch and Benesch, 1967, Miseta 
et al., 1993). To measure the effect of adenine nucleotides on p50 values, we titrated 
purified human adult Hb (Hb-A) with different concentrations of ATP, ADP, and AMP in 
the presence of physiological (1 mM) 2,3-BPG levels.  
We observed that the Hb-A p50 value is weakly affected by AMP (Figure 10 A 
and B) and, even at 10 mM AMP, the increase in the Hb-A p50 value is only about 1-2 
mmHg. Thus, the AMP increase in AMPD3-/- erythrocytes (Figure 9) should not alter its 
p50 value significantly.  
The effect of ADP concentration on Hb-A’s p50 value was linear up to 10 mM, 
with a steeper slope than seen for AMP (Figure 10). Nevertheless, based on results in 
Figures 10D and 9B, the three-fold increase in ADP concentration in Ampd3-/- 
erythrocytes predicts only a 0.2-0.5 mmHg increase in the p50 value of Hb-A. 
Therefore,  
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Figure 10. Adenine nucleotides’ effects on p50 of hemoglobin. Adenine nucleotide 
titrations at 37°C against human hemoglobin in the presence of 1 mM 2,3-BPG: A) and 
B) 5’-AMP, C) and D) ADP, and E) and F) ATP. The left-hand figures show the oxygen 
saturation curves for the various concentrations and the right-hand figures are plots of 
the p50 values from the saturation curve plotted against the respective adenine 
nucleotide concentration.  
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the increase in intracellular ADP is likely a negligible contributor to the observed rise in 
Ampd3-/- erythrocytes’ p50 value. 
The effect of ATP concentration on Hb-A’s p50 value was linear up to 10 mM, 
with a steeper slope (1.9 mmHg / mM) than seen for AMP (0.28 mmHg / mM) or ADP 
1.2) mmHg / mM) (Figure 10).  This difference indicates that ATP is more effective as a 
modulator of Hb-A p50 than the other two nucleotides. Based on the physiological 
concentrations of ATP in wild type mammalian erythrocytes of 1.0-2.5 mM, the data 
from Figures 9C and 10F predict that the 3.2-fold increase in ATP concentration in 
Ampd3-/- (versus wild type erythrocytes) would increase the Hb p50 value by 4-9 
mmHg. This value is consistent with the observed average difference in erythrocyte 
p50 values of about 6 mmHg. These findings suggest that the shift in p50 is primarily 
caused by the increase in intracellular ATP in the Ampd3-/- erythrocytes.  
3.2 Discussion 
Energy homeostasis in a living organism is maintained by regulation of systemic 
metabolism (Coll and Yeo, 2013). The role of erythrocytes in the regulation of systemic 
metabolic control is well recognized, as illustrated by the use of blood doping (artificially 
boosting the number of erythrocytes in circulation) to enhance athletic performance 
(Lundby et al., 2012, Vogel et al., 2014), or by the induction of hypothermia through 
blood loss (Ikeda, 1965, Marion et al., 1996). In our previous reports we have proposed 
that the erythrocyte adenylate equilibrium was perturbed upon an acute uptake of AMP 
(Daniels et al., 2010, Daniels et al., 2013), leading to systemic metabolic repression 
(Ikeda, 1965). These observations raised the question of how erythrocyte adenine 
nucleotide levels regulate oxygen transport and, thereby, systemic metabolism. As ATP 
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is the currency of consumable energy for biochemical reactions in cellular processes, 
its production and consumption must be tightly regulated (Dzeja and Terzic, 2009). The 
energy charge of the adenine nucleotide pool, as reflected in the adenylate equilibrium, 
ATP + AMP <=> 2ADP, reflects the balance of energy production and consumption in a 
cell (Dzeja and Terzic, 2009). The ultimate availability of ATP depends on the level of 
the total adenine nucleotide pool (ATP + ADP + AMP), which in turn depends on the 
rates of synthesis and degradation of one component of this pool, AMP (Ataullakhanov 
and Vitvitsky, 2002). The intracellular catabolism of AMP is primarily carried out by 
AMPD in the erythrocyte (Daniels et al., 2013). The three known tissue-specific 
isoforms of the enzyme, AMPD1, AMPD2 and AMPD3, are expressed in muscle, liver, 
and erythrocytes, respectively (Mahnke-Zizelman and Sabina, 1992). AMPD3 is the 
only isoform present in erythrocytes and it is expressed in other tissues at low levels 
(Daniels et al., 2013). Ampd3 expression is activated in response to energy imbalance 
(Chapman and Atkinson, 1993), oxidative stress (Tavazzi et al., 2001), or Ca2+-
calmodulin signaling (Mahnke and Sabina, 2005). Unlike cells of other tissues, 
erythrocytes have no salvage pathway that converts IMP back to AMP, because they 
are deficient in adenylosuccinate synthetase and lyase (Lowy and Dorfman, 1970). 
Thus, catabolism of AMP by AMPD3 in erythrocytes results in an irreversible loss of 
this nucleotide from the adenine nucleotide pool. Therefore, blocking AMP’s main 
catabolic pathway, by targeted gene disruption of Ampd3, could result in an enlarged 
pool of adenine nucleotides. The cellular adenylate equilibrium preferentially maintains 
the majority of the adenine nucleotide pool as ATP (Hardie et al., 1998). As expected, 
humans lacking AMPD3 have a large increase in ATP levels in their erythrocytes, as do 
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mice deficient in AMPD3 (Ogasawara et al., 1987; Cheng et al., 2012; Daniels et al., 
2013).  
In order to further understand how erythrocyte AMP levels regulate systemic 
metabolism, we generated mice deficient in the two major intra- and extracellular AMP 
catabolic enzymes, the Ampd3-/-/Cd73-/- model. Having shown that mice respond to an 
increase in AMP by entering AIHM (Daniels et al., 2010), we expected these mice to 
have a decrease in activity when compared to the wild type mice. Unexpectedly, we 
observed that the level of wheel running by Ampd3-/-/Cd73-/- mice was on average 3-
fold higher than wild type or Cd73-/- mice, and about 1.5-fold higher than Ampd3-/- mice 
(Figure 6). This differential in wheel running was consistent with the double knockout 
mice's elevated daily VO2 and food intake compared to those of wild type, Cd73
-/-, or 
Ampd3-/- mice. These observations suggest that the metabolic regulatory pathways of 
extracellular CD73 and intra-erythrocyte AMPD3 are physiologically linked. 
Interestingly, when the mice did not have access to exercise (i.e., no wheel in cage), 
the basal metabolic activities among the four genotypes were comparable. This 
suggests that much of the increase in VO2 of the Ampd3
-/-/Cd73-/- mice was driven by 
increased muscle activity during exercise and not by a general increase in basal 
metabolic state. We suspected that erythrocytes of the Ampd3-/-/Cd73-/- mice were able 
to deliver greater levels of oxygen to working muscles thereby supporting more 
sustained periods of wheel running and leading to greater levels of oxygen consumed. 
To provide for the larger energy consumption during exercise, the Ampd3-/-/Cd73-/- 
mice on average ate more food (Figure 7). 
The results above raised the question of just how the loss of both CD73 and 
AMPD3 results in erythrocytes delivering greater amounts of oxygen to muscle during 
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exercise. We suspected that this effect stems from the fact that the two enzymes 
together regulate the erythrocyte adenine nucleotide pool, acting at different cellular 
locations. When erythrocyte adenine nucleotides were measured in mice of the four 
genotypes (Figure 9), the total levels of adenine nucleotides in AMPD3 deficient mice 
(both AMPD3-/- and Ampd3-/-/Cd73-/-) were about three-fold higher than those from wild 
type or Cd73-/- mice. Remarkably, the ratio of ATP:ADP:AMP was still maintained close 
to 100:10:1 in the Ampd3-/- erythrocytes, presumably by the adenylate equilibrium 
system. Consequently, the majority of the increase in adenine nucleotides in the 
Ampd3-/- erythrocytes came from the increase in ATP levels. When comparing the 
levels of ATP and ADP in Ampd3-/-/Cd73-/- versus Ampd3-/- erythrocytes, the levels in 
the former were significantly elevated suggesting CD73 has an additive contribution to 
the increase of intracellular levels of adenine nucleotides in erythrocytes. Taken 
together, these data suggest that the increase in the adenine nucleotides is partly 
responsible for allowing the erythrocytes to deliver more oxygen in AMPD3 deficient 
mice (both AMPD3-/- and Ampd3-/-/Cd73-/-). 
These findings of the increase in adenine nucleotide levels in the AMPD3 
deficient mice led to the question of how the change in erythrocyte adenine nucleotide 
levels results in an increase in systemic metabolism. We reasoned that erythrocytes’ 
regulation of metabolism likely involves regulation of the erythrocytes' main biological 
function, namely oxygen transport. When comparing erythrocytes from the 4 genotypes 
of mice (Figure 8), those from mice deficient in AMPD3 had p50 values that were on 
average about 6 mmHg higher compared with those from mice with functional AMPD3, 
indicating that the loss of AMPD3 is the main contributor to the observed increase in 
the p50 values. Intriguingly, whereas the average p50 value of Ampd3-/-/Cd73-/- 
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erythrocytes was noticeably higher than that from the Ampd3-/- genotype, the p50 
values of CD73-/- erythrocytes were similar to those of wild type. These observations 
suggest that the role of CD73 in regulating erythrocyte adenine nucleotides becomes 
more prominent in the absence of AMPD3 while suggesting that the increase in ATP 
levels in the mice without functional AMPD3 was directly resulting in the increase in 
systemic metabolism as measured by the wheel running activity from figure 6.  
We then examined how changes in adenine nucleotide levels affect the p50 of 
Hb. Do they act as direct modulators or do they act indirectly via changes in 2,3-BPG or 
pH? We found erythrocyte 2,3-BPG levels among mice of the four genotypes were 
similar (Figure 8). Furthermore, erythrocyte intracellular pH values of all 4 genotypes of 
mice were well within the established pH range of normal erythrocytes (Funder and 
Wieth 1966). Based on these findings, we conclude that the increase in p50 values 
observed in Ampd3-/- erythrocytes was not driven by increased 2,3-BPG levels or 
decreased intracellular pH. We then tested whether adenine nucleotides can regulate 
the p50 of Hb either directly or through another mechanism. Hb’s affinity for oxygen can 
be regulated by many types of organic phosphates (Benesch and Benesch, 1967), so 
we examined the effects of adenine nucleotides on the p50 values of purified Hb-A. 
Consistent with findings from Benesch and Benesch (1967), we observed that ATP and 
ADP increased purified Hb-A p50 values (Figure 10). We observed a linear correlation 
between increasing concentrations of ATP or ADP with increases in p50 values of Hb-
A. Consistent with previous findings, we observed that AMP has only a weak effect on 
purified Hb-A affinity for oxygen (Lo and Schimmel, 1969). While ADP can significantly 
alter Hb affinity for oxygen and increase its p50 value, the concentration required to 
shift the p50 by about 6 mmHg was estimated to be about 5 mM based on the 
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correlation between p50 values and ADP concentration shown in Figure 10D. Given 
that the physiological concentration of intracellular ADP in wild type erythrocytes is 
between 0.1-0.2 mM, a three-fold increase in this concentration cannot account for the 
observed Ampd3-/- erythrocytes’ increase in p50 values. The concentration of ATP in 
wild type erythrocytes is between 1-2.5 mM (Benesch and Benesch, 1967, Miseta et 
al., 1993). We observed that ATP at this concentration can potently increase Hb’s p50 
value. Our present study shows that the loss of AMPD3 results in about a three-fold 
increase in ATP levels compared with wild type erythrocytes. This would put the 
estimated ATP concentration in AMPD3 deficient erythrocytes at between 3-7.5 mM, 
comparable to the reported Kd (2.55 mM) of ATP binding to the Hb-A (Benesch and 
Benesch, 1974). Based on the correlation between ATP concentration and Hb p50 
value, we estimate this increase in Ampd3-/- erythrocyte ATP levels would generate an 
increase of between 4 to 9 mmHg in Hb p50 values, in line with the increase observed 
in Ampd3-/- erythrocytes. Thus, it is reasonable to conclude that accumulation of ATP in 
erythrocytes contributes to the majority of the increase in p50 values of AMPD3-
deficient over normal erythrocytes.  
Our studies identify AMPD3 as a major regulator of the adenine nucleotide pool 
in the erythrocytes. While the loss of CD73 itself appears to have little impact on the 
erythrocytes’ p50 value, we can only speculate on the impact of extracellular AMP 
influx into erythrocytes deficient in AMPD3 in vivo. We reason that AMP influx must 
exert a dynamic and significant impact on the erythrocytes’ ability to release oxygen, 
since systemic metabolism and the total adenine nucleotide pool are significantly 
elevated in Ampd3-/-/Cd73-/- compared to Ampd3-/- mice.  
 It has been argued that Hb binding of oxygen is too tight in the absence of 
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organic phosphate to be physiologically useful (Garby et al., 1969). Hb binding of 2,3-
BPG lowers the Hb affinity for oxygen to a range where H+, CO2, and other organic 
phosphates that occur at lower physiological concentrations could then fine tuned Hb 
affinity for oxygen. Since 2,3-BPG is the metabolite that can be synthesized without 
perturbing the adenylate ratios, the possible role of the adenine nucleotides in 
modulating Hb affinity for oxygen has not been considered important (Garby et al., 
1969). By contrast, other studies have implicated the importance of ATP in regulating 
Hb affinity for oxygen (Weber and Lykkeboe 1978). In some ectothermic species, such 
as fish, ATP has been shown to be a major mediator of Hb’s affinity for oxygen (Gupta 
et al., 1978). Our present studies indicate that the mammalian erythrocyte ATP levels 
are a major modulator of Hb affinity for oxygen, similar to ectothermic species.  
 Previous studies have demonstrated that both ATP and 2,3-BPG bind to Hb 
with comparable affinity (Benesch and Benesch, 1974, Weber and Lykkeboe, 1978, 
Gupta et al., 1979). Here, we have carried out measurements of ATP’s effects on Hb-
A p50 values in the absence and presence of 2,3-BPG (Figure 11). The p50 values 
obtained in the presence and absence of 2,3-BPG over a range of ATP concentrations 
were nearly parallel suggesting that the effects of 2,3-BPG and ATP on Hb-A p50 
values are additive. Since both of these organic phosphates occur in erythrocytes at 
physiological concentrations in the millimolar range, it is likely that the Hb p50 value is 
regulated in part by the total intracellular levels of 2,3-BPG and ATP. Thus, we 
propose that a change in erythrocyte ATP levels during metabolic activities could be a 
mechanism to achieve finer dynamic control of oxygen delivery to tissues.  
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Figure 11. ATP’s efficacy on p50 shift of HbA in the presence and absence of 2,3-
BPG. ATP titration against HbA in the presence and absence of 1mM 2,3-BPG.  
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4. Unraveling the mechanism of 5’-AMP induced hypometabolism in mouse 
models 
4.1. Results 
4.1.1. Analysis of AIHM and torpor response in mice with deficiency in CD73 and 
AMPD3.  
 Having analyzed the physiological impact of deficiency in both AMPD3 and 
CD73, we next investigated how these mice would respond to AIHM compared to wild 
type or mice deficient in either AMPD3 or CD73. First, we measured and compared the 
length of time mice remain in AIHM or induced torpor, in response to a sub-obtimal 
dose of AMP (0.2 mg/gw) to see if the Ampd3-/-/Cd73-/- mice were more sensitive to 
AMP. Throughout this experiment, the mice were kept in a Comprehensive Lab Animal 
Monitoring System (CLAMS) with the ambient temperature (Ta) set at 15
°C and the VO2 
of individual animals was recorded. For the analysis of this experiment, we considered 
an animal to be in a torpor state when its VO2 dropped below 1200 mL/kg/h. We 
previously have shown that mice deficient in either CD73 or AMPD3 stayed in AIHM 
longer than wild type mice when given a lower dose of AMP (Daniels et al., 2010, 
Daniels et al., 2013). Here, we observed that mice deficient in both CD73 and AMPD3 
remained in AIHM for an average length of 9h, while wild type mice failed to enter the 
AIHM state with VO2 levels staying above 1200 mL/kg/h after AMP injection (Figure 
12). The VO2 of most of the Ampd3
-/- mice dropped below 1200 mL/kg/h for an average 
length of 2 h. The Cd73-/- mice responded more severely than the Ampd3-/- mice, 
typically staying in the AIHM for an average length of 6 h. Next, we compared the 
length of AIHM of the different genotypes upon receiving the optimal dosage of AMP 
(0.5 mg/gw). At this dosage all the mice in these studies entered deep AIHM after 2  
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Figure 12. Loss of AMPD3 and CD73 impact on AIHM under sub-optimal AMP 
dose. Mice from each genotype (N=3) were injected with a sub-maximal dose of AMP 
(0.2 mg/gbw) and placed at an ambient temperature of 15°C. The amount of time in 
AIHM was calculated from injection to when they increase their VO2 to 1200 mL/kg/h 
or, in the case of the wild type mice, until their VO2 starts to increase. P values = * < 
.05, ** < .005, and *** < .0001. 
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hours following administration of AMP. The cohort of wild type mice had the shortest 
average length of AIHM (Figure 13 A and E). Over 90% of wild type mice had already 
aroused from AIHM 10 h following AMP administration. In contrast, at 10 h, over 60% 
of Ampd3-/- mice and about 95% of Cd73-/- and Ampd3-/-/Cd73-/- mice were still in AIHM 
(Figure 13 B, C, D, and E). The difference between Cd73-/- and Ampd3-/-/Cd73-/- mice 
became apparent 12 h after AMP administration when about 65% of Cd73-/- mice 
remained in AIHM but no change was observed for Ampd3-/-/Cd73-/- mice. After 14 h, 
when the experiment was terminated as required by our AWC protocol, the number of 
Ampd3-/-/Cd73-/- mice that remained in the AIHM state had not changed. Together, 
these data demonstrate that CD73 and AMPD3 regulate the potency and length of 
AIHM. 
4.1.2. Manipulation of Extracellular AMP modulates erythrocyte p50.  
 The above findings raise the question of how CD73 and AMPD3 could regulate 
the efficacy of 5’-AMP in mediating AIHM and the subsequent effects of torpor. Given 
the above findings that the AMPD3 deficient erythrocytes naturally displayed increased 
p50 values as a result of a physiological increase in adenine nucleotide levels, we 
reasoned that the observed increased response to AMP in inducing the AIHM state 
could be due to a direct or indirect effect of AMP affecting the p50 value of 
erythrocytes. Figures 8 and 9 showed that the double deficiency of CD73 and AMPD3 
led to changes in levels of erythrocyte adenine nucleotides, which shifted the Hb p50 
values. Here, we ask whether the addition of extracellular AMP could shift the 
erythrocyte p50. We have estimated that an IP injection of 0.5 mg/gw of AMP would 
result in an extracellular AMP concentration of about 14.4 mM based on an estimated 
blood volume of 10% of the body weight.   To investigate the effect of AMP on the p50  
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Figure 13. Loss of AMPD3 and CD73 impact on AIHM under optimal dose. (A-D) 
Mice from each genotype (A: wild type (N=16), B: Ampd3-/- (N=15), C:Cd73-/- (N=15), 
and D: Ampd3-/-/Cd73-/- (N=16)) were injected with the optimal dose of AMP (0.5 
mg/gbw) and placed at an ambient temperature of 15°C. The length of time each 
mouse stayed in AIHM was calculated from injection to when their VO2 return to above 
1200 mL/kg/h. E) Graphical representation of all four genotypes and the percent of 
injected animals over time. Sampling of animals in AIHM were taken every 2 h. P 
values = * < .05, ** < .005, and *** < .0001. 
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of the erythrocytes, we first tested a lower concentration of AMP (2 mM) on isolated 
mouse Ampd3-/-/Cd73-/- erythrocytes (Figure 14 A and B); we observed a significant 
increase in p50 and a rightward shift in the oxygen saturation curve suggesting that 
AMP is lowering the erythrocytes’ affinity for oxygen. The Ampd3-/-/Cd73-/- erythrocytes 
were used to exclude the possibility of an indirect effect of AMP via dephosphorylation 
to adenosine. In addition, we carried out similar experiments with the same 
concentration of adenosine (2 mM) on isolated Ampd3-/-/Cd73-/- erythrocytes. 
Compared to the vehicle solution, the addition of adenosine did not alter the 
erythrocytes’ p50 significantly (Figure 14 C). This result further excluded the possibility 
that this shift in p50 was due to adenosine. Among all four genotypes, the isolated 
erythrocyte responses to AMP-induced p50 shifts were comparable (Figure 14 D). 
Next, we wanted to test the response of the erythrocytes closer to the AIHM-
inducing concentration, estimated at about 15 mM. We observed that the oxygen 
dissociation curve of the isolated mouse erythrocytes was shifted to the right by 
extracellular concentrations of 2-20 mM AMP with a linear (r2=0.992) increase in p50 
(Figure 14 E and F). Interestingly, despite the large shift in p50 induced by high AMP 
concentrations, the Hill co-efficient of the erythrocytes in the p50 experiments was not 
altered (Figure 14 G), indicating that the change in cooperativity of the Hb was not 
responsible for the large shift in p50 values.  
These studies clearly demonstrate that extracellular AMP, not adenosine, 
modulates intact erythrocyte’s p50 values. The p50 shift induced by extracellular 5’-
AMP could either act indirectly via a previously unrecognized AMP-receptor mediated 
mechanism or directly after being taken up by erythrocytes (Daniels et al., 2010). We 
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Figure 14. Effect of AMP on the p50 of intact erythrocytes. A) Erythrocytes oxygen 
saturation curve after addition of 2 mM AMP. B) Average erythrocytes p50 values in 
saline and 2 mM AMP (N=3). C) Average erythrocytes p50 values in vehicle and 2 mM 
Adenosine (N=3). D) Shift of p50 after 2 mM AMP incubation in the four genotypes 
(N=3). E) Erythrocytes oxygen saturation curves in response to extracellular AMP 
concentration. F) Plot of p50 values from E. G) Plot of the Hill coefficients from E. P 
values = ** < .005. 
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reasoned that a receptor based mechanism depends on the integrity of the cell. 
Therefore, if extracellular AMP depends on receptor-mediated mechanism to induce 
p50 shift, then this response should be abolished when erythrocytes were lysed. 
Double freeze-thawed Ampd3-/-/Cd73-/- whole erythrocyte lysate was used to 
investigate this possibility. Evidence of the erythrocytes having undergone lysis was 
marked by the baseline change in p50 value in the absence of AMP. Intact mouse 
erythrocytes’ p50 is approximately 40 mmHg. In contrast, lysate of mouse erythrocytes 
gave a baseline p50 of about 20 mmHg (Figure 15 A). Titration of the erythrocytes’ 
lysate against different AMP concentrations revealed a linear p50 shift that correlates 
with AMP concentration and is independent of the erythrocytes lysate volume used 
(Figure 15 B and C). In addition, we observed that the level of p50 increase induced by 
AMP, whether in isolated Ampd3-/-/Cd73-/- erythrocytes or its lysed counterpart, were 
comparable (Figure 15 D). The slopes (m) measured as the change in p50 as a 
function of AMP concentration were m=1 for whole erythrocytes and m=0.89 for the 
lysates. Together, these data show that the AMP-induced erythrocyte’s p50 increase 
was not altered by disruption of the erythrocyte cell membrane suggesting against a 
receptor mediated mechanism. 
4.1.3. Direct uptake of AMP by erythrocytes.  
The above finding is consistent with our previous observations that erythrocytes 
can uptake AMP directly (Daniels et al., 2010). Although uptake of AMP by erythrocytes 
had been independently observed (Mathews et al., 2005), the characteristics and 
kinetics of this uptake remain unclear. We wanted to further investigate the mechanism 
of AMP uptake. Erythrocytes have equilibrative nucleoside transporters (ENTs) that 
readily uptake adenosine, which can be rephosphorylated into AMP by adenosine  
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Figure 15. Effect of AMP on lysed erythrocytes and intact erythrocytes. A) Oxygen 
saturation curve of intact and lysed erythrocytes showing both a shift in baseline p50 
value after lysis and a change in the curve shape. B) Oxygen saturation curve of 
erythrocyte lysate incubated with various concentrations of AMP. C) Plot of the change 
in p50 values in response to an AMP titration with different amounts of lysate. D) Plot of 
the change in p50 values in response to an AMP titration in intact and lysed 
erythrocytes.  
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kinase intracellularly. An experiment was designed to investigate whether the AMP was 
taken up directly or indirectly as a result of rephosphorylated adenosine. First, we 
verified that the dephosphorylation of AMP to adenosine by CD73 is truly absent in 
Cd73-/- mouse blood, using wild type mouse blood as a control. The cell lysates and 
supernatants, from a time-course of incubation of [14C]-AMP with whole blood from the 
two genotypes, were profiled by thin-layer chromatography (TLC) (Figure 16 A). 
Interestingly, in cell fractions of both genotypes, the TLC displayed detectable levels of 
[14C]-AMP, even at 5 min incubation, suggesting that AMP had already entered the 
erythrocytes. In addition, some ADP has formed from [14C]-AMP through adenylate 
equilibrium, similar to our earlier observation (Daniels et al., 2011). The TLC analysis 
further revealed that the majority of [14C]-AMP was already catabolized in wild type 
whole blood supernatant after a 15 min incubation at 37°C. By contrast, the majority of 
[14C]-AMP remained intact in the supernatant of Cd73-/- whole blood even after 1h of 
incubation at 37°C. These findings are consistent with CD73 being the major 
extracellular catabolic enzyme for AMP (Castrop et al., 2004) and give confidence that 
studies using tissues deficient in CD73 would significantly eliminate dephosphorylation 
of AMP into adenosine.  
Next, we investigated whether isolated erythrocytes would dephosphorylate 
AMP into adenosine, addressing the question of whether CD73 or other AMP catabolic 
enzymes are directly associated with erythrocytes. The isolated and washed 
erythrocytes were incubated with [14C]-AMP over a time course spanning 5 h at 37°C. 
Cell and supernatant fractions were separated and analyzed by TLC (Figure 16 B). 
Both isolated erythrocytes from wild type and Cd73-/- mice did not catabolize [14C]-AMP 
significantly even after 5 h of incubation at 37°C. In addition, the uptake of [14C]-AMP  
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Figure 16. Stability of extracellular AMP in whole blood and in isolated 
erythrocytes. A) Whole blood incubation of [14C] AMP from wild type and Cd73-/- mice. 
B) Isolated erythrocyte incubation of [14C] AMP from wild type and Cd73-/- mice Note: x-
ray film exposure time was selected to favor signals in the supernatant. 
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into the erythrocytes was comparable between the two genotypes. These studies 
demonstrated that uptake of [14C]-AMP by erythrocytes can be direct and that CD73 is 
not associated directly with erythrocytes.  
Finally, we investigated whether erythrocytes could also directly uptake other 
adenine nucleotides. Since it has been demonstrated that CD39/ATPase would convert 
ATP into ADP and then into AMP extracellularly (Wang and Guidotti, 1996), we 
investigate whether [14C]-ADP would be taken up directly. Isolated CD73-/- erythrocytes 
were incubated with [14C]-ADP over a 3 h time course. Cell and supernatant fractions 
were then separated at specific time points of incubation and analyzed by TLC (Figure 
17). From the supernatant fraction, we observed that a significant levels of [14C]-ADP 
had already been dephosphorylated into [14C]-AMP after 5 min of incubation with 
isolated erythrocytes at 37°C. In the cell fraction, within the first 5 min we observed 
[14C]-AMP but no apparent levels of [14C]-ADP. No significant level of [14C]-ADP was 
detected in the cells even after 30 min of incubation. By this time, the majority of the 
supernatant [14C]-ADP had already been dephosphorylated to [14C]-AMP. After 1 h, 
both [14C]-AMP and [14C]-ADP were detected inside the erythrocytes but the increase in 
[14C]-ADP coincided with decreases in [14C]-AMP levels suggesting that the rise in 
[14C]-ADP could be a result of the erythrocytes adenylate equilibrium rebalancing the 
cellular adenine nucleotides ratio rather than via ADP uptake by the erythrocytes. 
Together, these studies suggest that the outer membrane of erythrocytes contained 
CD93/ATPase but not CD73, or another 5’-nucleotidase, and that erythrocytes readily 
uptake AMP but not ADP. 
4.1.4. Kinetics of AMP uptake by erythrocytes. 
To better understand the uptake of AMP by erythrocytes, we investigated the  
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Figure 17. Kinetics of ADP metabolism by isolated erythrocytes. A suspension of 
washed erythrocytes (150 x 106 cells in 15 μl) was incubated with 1 mM [14C] AMP at 
37°C for the indicated lengths of time before the nucleotide products inside (cells) or 
outside (supernatant) the erythrocytes were extracted and analyzed by TLC.  
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kinetics of this uptake process. We reasoned that if this uptake was enzymatically 
mediated, we should be able to calculate the Km and Vmax of the corresponding protein. 
Radiolabelled [14C]-AMP was incubated with isolated wild type mouse erythrocytes at 
37°C. At specific time points of this incubation, aliquots of the reaction mixture were 
separated by centrifugation into cell and supernatant fractions. The cell fraction was 
further washed 3 times with 1ml PBS, and the supernatant of the initial wash was kept. 
The levels of radioactivity in the cell, supernatant, and first wash fractions were then 
determined with a scintillation counter. The percentages of the radioactivity from the 
three fractions were plotted against the time of incubation (Figure 18 A). We observed 
that the percentage of radioactivity in the wash fraction was constant over the entire 
time course. The supernatant fractions have the highest percentage of radioactivity at 
the beginning of the time course, but the levels declined over time. Corresponding to 
this decline, the radioactivity in the cell fraction, which was lowest at the beginning of 
the time course, now increased over time. We observed a reciprocal inversion of 
radioactivity between cell and supernatant fractions, which was linear during the initial 2 
h of the incubation.  
Based on conditions established in the experiment above, the amount of AMP 
uptake was measured against the extracellular AMP using a 45 m incubation period at 
37°C. We observed that erythrocytes’ uptake of AMP was linearly related (r2= 0.97) to 
the extracellular concentration of AMP, up to 10 mM for isolated wild type (Figure 18 B) 
and Cd73-/- erythrocytes (Figure 18 C). There was no major difference between wild 
type and Cd73-/- erythrocytes at extracellular AMP concentrations above 1 mM. 
However, within the concentration range below 1 mM, we observed a “saturable” 
component from wild type but not in CD73-/- erythrocytes (Figure 18 D and E). We  
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Figure 18. Concentration dependence of AMP uptake by erythrocytes. A) The 
fractions of total added radioactivity in the supernatant, erythrocyte, and wash fractions 
at the indicated times after adding [14C]-AMP (1 mM) to suspended erythrocytes (150 x 
106 cell/ 15 μl) at 37°C. Uptake of AMP by wild type (B) and Cd73-/- (C) erythrocytes up 
to 10 mM extracellular AMP. Plots of up take in the range of 0 - 1 mM extracellular 
AMP concentrations in wild type (D) and Cd73-/- (E) erythrocytes. 
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reasoned that wild type samples have trace amounts of CD73, likely from the low level 
of white blood cells that were not completely removed when the erythrocytes were 
isolated. The CD73 dephosphorylates the extracellular AMP to adenosine, which can 
then enter the erythrocytes via the ENTs. This small adenosine uptake due to the trace 
amount of CD73 “contamination” in the wild type isolated erythrocytes. Above 0.1 mM 
extracellular concentration, the AMP uptake was linear, as such the Km and Vmax values 
could not be determine. Together, these findings suggest that erythrocytes have a very 
large relative capacity to uptake extracellular AMP, presumably through a pore or 
channel. 
As mentioned above, we surmised that this uptake could be based on 
membrane pores or specific channels. However, there is no known channel(s) for 
transporting AMP across the erythrocyte membrane. There are known adenine 
nucleotides transporters, ATP-ADP translocase (ANT), which are members of the 
solute carrier family 25 (slc25) proteins in the mitochondria (SLC25a 4-6 and 31) and 
peroxisomes (SLC25a17). The mitochondria but not the peroxisomes ANT’s are 
sensitive to carboxyatractyloside (CAT) inhibition (Guitierrez-Aguilar and Baines, 2013). 
Therefore, we carried out an uptake study to determine if CAT had an impact on AMP 
uptake by the erythrocytes. We observed that the erythrocytes’ uptake of AMP was not 
significantly affected by the addition of CAT (Figure 19 A). 
Erythrocytes express ENT1 that mediates the uptake of adenosine. Could ENT1 
also mediate the uptake of AMP? Since ENT1 is sensitive to inhibition by dipyridamole, 
we examined the AMP uptake of erythrocytes in the presence of 10 µM dipyridamole. 
We found that the AMP uptake was not significantly affected by the addition of 
dipyridamole (Figure 19 B).  
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Figure 19. Inhibitors of AMP uptake by erythrocytes. A) CAT effect on erythrocytes 
AMP uptake. B) Dipyridamole (Dip) effect on erythrocytes AMP uptake. C) Tannic Acid 
(TAN), inhibition of erythrocytes AMP uptake. D) Titration of TAN concentration against 
erythrocytes AMP uptake. 
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Next, we investigated whether chloride channel inhibitor Tannic Acid (TAN), 
which has been shown to be a highly effective inhibitor of adenine nucleotide 
transporter (SLC25a family) and Ca2+ and Cl- ion channels (Namkung et al., 2010), had 
an effect on AMP uptake. We observed a strong inhibitory effect on erythrocytes’ 
uptake of radiolabeled [14C]-AMP by 0.2% of TAN, a commonly used dose (Figure 19 
C). Next, we carried out a titration for the effective dose of TAN on inhibition of AMP 
uptake (Figure 19 D). We observed that the amount of AMP uptake by the erythrocytes 
was significantly reduced when the concentration of TAN decreased to below 0.01%. 
We could conclude that AMP uptake was sensitive to TAN interaction with the 
erythrocytes. Together, these studies suggest that uptake of AMP by erythrocytes is 
insensitive to CAT inhibition but is sensitive to TAN inhibition.  
Next, we investigate if the erythrocytes’ AMP uptake is competively inhibited by 
cellular metabolites. We examined various common cellular metabolites including ATP, 
ADP, adenosine, cAMP, CMP, GMP, glucose, lactate, and urea. The uptakes of [14C]-
AMP by wild type erythrocytes with and without 1 mM of the competing metabolite were 
compared (Figure 20 A). We observed that glucose, urea, lactate, and adenosine had 
minimal effect on AMP uptake by erythrocytes. While all nucleotides tested show some 
level of inhibition of or competition with [14C]-AMP uptake, cAMP is the least effective 
one, followed by CMP. The inhibition effect of ATP was as strong as unlabeled AMP, 
while ADP was only slightly less effective. Interestingly, GMP appeared comparable to 
ADP in inhibiting uptake or in competing with AMP for uptake by erythrocytes. We 
further characterized this putative inhibition by GMP on AMP uptake by the 
erythrocytes by comparing the effect of increasing extracellular AMP in the presence 
and absence of 1 mM GMP (Figure 20 B). We observed that the rate of AMP uptake  
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Figure 20. Competitive nucleotide inhibitors of AMP uptake by erythrocytes. A) 
AMP uptake inhibition assay using common metabolites and nucleotides/nucleoside. B) 
Examining GMP inhibition of AMP uptake under increasing concentration of 
extracellular AMP.  
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was driven by the extracellular concentration and was not inhibited by GMP. Together 
these studies suggest that the putative channel/pore for AMP uptake by erythrocytes 
has some level of specificity to adenine nucleotides. 
4.1.5. AMP uptake leads to change in intracellular adenine nucleotide levels. 
Physiological AMP levels in the wild type erythrocytes have been estimated to 
be about 25 µM. The above findings that erythrocytes’ uptake of AMP was linear, even 
when the extracellular AMP level was 20 mM, raises the question as to its impact on 
the erythrocyte adenylate pool and its link to the large p50 increase observed. To 
obtain measurements of intracellular adenine nucleotide levels correlated to various 
levels of extracellular AMP, isolated erythrocytes from each of the genotypes were 
incubated with varying concentrations of extracellular AMP, up to 20 mM at 37°C. After 
15 min, the cells were separated from the supernatant, washed, and the cell’s 
nucleotides were extracted using acid extraction methods. The neutralized cell extracts 
were analyzed by HPLC. Based on ATP, ADP, and AMP standards and their 
absorbance spectra, the levels of each of these adenine nucleotides in the respective 
erythrocyte samples were determined. Here we show the data obtained from 
erythrocytes from each genotype (Figures 21, 22, 23). Even though the levels of 
erythrocyte adenine nucleotides were 3 times higher in the AMPD3-/- genotypes, the 
erythrocytes from all the genotypes in these studies show similar correlative trends as 
described below.  
Similarly to the AMP uptake experiments using [14C]-AMP, the HPLC 
approaches also revealed a linear uptake of AMP into the cell that is driven by the 
concentration of extracellular AMP (Figure 21). At 20 mM extracellular AMP, the 
intracellular AMP has increased over 30-fold from the physiological level. The HPLC  
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Figure 21. Erythrocytes intracellular AMP after incubation with increasing 
extracellular AMP concentration A-D) Erythrocytes intracellular levels of AMP in 
each of the four genotypes after extracellular AMP incubation (A: wild type, B: Ampd3-/-, 
C: Cd73-/-, and D: Ampd3-/-/ Cd73-/-). 
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Figure 22. Erythrocytes intracellular ADP after incubation with increasing 
extracellular AMP concentration A-D) Erythrocytes intracellular levels of ADP after 
extracellular AMP incubation in each of the four genotypes (A; wild type, B; Ampd3-/-, 
C; Cd73-/-, and D; Ampd3-/-/ Cd73-/-). 
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Figure 23. Erythrocytes intracellular ATP after incubation with increasing 
extracellular AMP concentration A-D) One plot for erythrocytes of each of the four 
genotypes (A; wild type, B; Ampd3-/-, C; Cd73-/-, and D; Ampd3-/-/ Cd73-/-). [Tre, see if 
you can plot the inverse trace of the initial ATP decreased] 
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analysis revealed relatively small changes to intracellular ADP despite large increases 
in AMP (Figure 22). The level of intracellular ATP initially decreased rapidly when 
erythrocytes were incubated with extracellular AMP below 2 mM. At higher extracellular 
AMP levels, there was little change to the levels of intracellular ATP levels (Figure 23).  
These findings were somewhat surprising since we would have expected the 
ratio of the three nucleotides to be regulated by the adenylate equilibrium, AMP + ATP 
 2 ADP. When we plot the ATP:AMP ratio relative to the extracellular AMP 
concentration, we observed that the drop in the ATP:AMP ratio is inversely exponential 
(r2=0.991) to extracellular AMP concentrations (Figure 24). Our analysis revealed a 
smaller change to intracellular AMP result in a large drop in intracellular ATP levels, 
especially when extracellular AMP is below 1 mM. However, further increased in 
intracellular AMP do not generate corresponding decreased the intracellular ATP 
levels.  
In addition, we also plot the ATP:ADP ratio against extracellular AMP, we 
observed that the ATP:ADP ratio is inversely linear (r2=0.977) to the concentration of 
extracellular AMP (Figure 25). Since the cellular levels of ADP remained relative 
constant, the large drop in ATP as a result of a smaller increase in AMP is rather 
perplexing. The ratio of ATP:AMP induced by the influx of AMP into the erythrocytes 
appears inconsistent with the rebalancing of the adenylate equilibrium controlling ratio 
of ATP:ADP:AMP. This ratio is approximately 100:10:1 observed in a wild type 
physiological state. At a 1 mM extracellular AMP concentration, the erythrocytes’ 
intracellular ATP:AMP ratio has dropped from over 100:1 to 25:1, a 4-fold change. 
Given that the intracellular ADP concentration appeared relatively constant, it suggests 
that either a significant amount of the ATP is rapidly degraded or is somehow lost from  
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Figure 24. Erythrocytes intracellular ATP:AMP ratio after incubation with 
increasing extracellular AMP concentration. A-D) One plot for erythrocytes of each 
of the four genotypes:  (A; wild type, B; Ampd3-/-, C; Cd73-/-, and D; Ampd3-/-/Cd73-/-). 
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Figure 25. Erythrocytes AMP uptake and its correlation with intracellular 
ATP:ADP ratio. A-D) One plot for erythrocytes of each of the four genotypes (A; wild 
type, B; Ampd3-/-, C; Cd73-/-, and D; Ampd3-/-/Cd73-/-). 
.  
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the erythrocytes. Together, these findings indicate that the influx of AMP into the 
erythrocytes can occur at non-physiological levels, which then alters the adenine 
nucleotide ratios inconsistently with the established adenylate equilibrium.  
4.1.6. Influx of AMP induces ATP Release from erythrocytes. 
We were surprised by the observations that the intracellular ATP:AMP ratio 
decreased only during the initial incubation with extracellular AMP and that it does not 
change much after this initial rapid drop even when extracellular AMP concentrations 
increased significantly. We reasoned that this initial loss of ATP is not a result of rising 
intracellular AMP concentration driving ATP catabolism. Since there is no 
corresponding large increase in ADP, the dephosphorylated product of ATP, we 
investigated the possibility that the intracellular ATP could have been released by the 
erythrocytes during the initial influx of AMP.  
Given the possibility that extracellular ATP can be quickly degraded by 
ATPase’s that are associated with erythrocytes, a luminometer, Lumicycle (Actimetrics, 
IL, USA), was used to monitor the ATP release with an ATP-activated luciferase assay 
in real-time. Induced ATP release from isolated erythrocytes was measured when the 
erythrocytes were incubated with saline (control), 5’-AMP, other nucleotides (3’-AMP, 
5’-CMP, 5’-GMP, IMP, and 5’-3’-cAMP), or adenosine at 1 mM concentrations (Figure 
26 A). Interestingly, responses above the PBS control levels of ATP activated 
luciferase activities were observed for 5’-AMP and, to a small extent, 3’-AMP but not for 
the other nucleotides and nucleosides tested (Figure 26 A and B). Again, adenosine, 
unlike 5’-AMP, was no more effective in inducing ATP release from erythrocytes than 
PBS (Figure 26 C). Together, these studies demonstrate that influx of AMP into 
erythrocytes was accompanied by efflux of ATP, which could explained the absence of  
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Figure 26. Nucleotides’ induction of ATP release by erythrocytes. A) ATP 
luciferase time course after addition of nucleotides and adenosine. B) Quantification of 
multiple samples of various nucleotides (N=3). C) Quantification of multiple samples of 
AMP and adenosine (N=3). P values = *** < .0001. 
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ADP increase predicted under the adenylate equilibrium control.   
Next, we investigated whether the efflux of ATP from the erythrocytes that was 
stimulated by AMP influx could be inhibited by ion channels blockers. Considering the 
earlier observation that tannic acid blocks AMP uptake, we first investigated whether 
tannic acid could block ATP release. We observed that tannic acid could potently inhibit 
ATP released by erythrocytes, but further characterization of this activity revealed that 
tannic acid may directly inhibit the luciferase enzyme rendering these findings 
ambiguous.  
Studies have reported that ATP released by erythrocytes was mediated by the 
pannexin channel, PANX1, which is sensitive to blockage by carbenoxolone (10 µM) 
(Montalbetti et al., 2011). Therefore, we investigated whether ATP released by 
erythrocytes induced by AMP uptake could be blocked by carbenoxolone. ATP release 
by erythrocytes induced by AMP was measured in the absence or presence of 1 µM, 
10 µM and 100 µM carbenoxolone (Figure 27 A). We observed that AMP-induced 
release of ATP from erythrocytes was not blocked by carbenoxolone. If anything, at the 
highest carbenoxolone concentration, we observed some level of additional AMP-
mediated ATP release.  
In another independent study, it was reported that the voltage-dependent anion 
channel (VDAC) inhibitor TRO19622 could inhibit ATP release from erythrocytes 
(Sridharan et al., 2012). Therefore, we undertook studies to investigate whether AMP 
mediated ATP release by erythrocytes could be blocked by TRO19622. ATP released 
by erythrocytes stimulated by 1 mM AMP was titrated against increasing concentrations 
of TRO19622 (Figure 27 B). We observed that the erythrocytes’ ATP release 
stimulated by AMP was sensitive to inhibition by TRO19622 above 1 µM. These  
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Figure 27. Inhibitors of ATP release by erythrocytes. A) Effect of CBX on ATP 
release stimulated by AMP. B) Effect of TRO19622 on ATP release stimulated by AMP. 
C) Effect of Ca2+ on ATP release stimulated by AMP. 
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observations suggest that the channel that is mediating AMP influx and/or ATP efflux 
could be a member of the VDAC family. Since VDAC is implicated in the ATP export 
process by TRO19662 and VDAC is known to be a major calcium exporter during 
apoptosis, we investigated whether calcium could modulate the AMP mediated ATP 
released from erythrocytes (Figure 27 C). We observed a correlation between 
increased calcium concentrations up to 100 µM and the inhibition of AMP-mediated 
ATP release from erythrocytes with an IC50 value of ~9 µM. In addition to calcium, we 
investigated another divalent ion, magnesium. Unlike calcium, we observed that 
magnesium stimulated luciferase activity but had no effect on AMP-mediated ATP 
release by erythrocytes. These findings suggest that the AMP-mediated ATP release 
by erythrocytes is regulated by calcium. Together these studies demonstrate that the 
AMP mediated release of ATP by the erythrocytes is likely mediated by an ion 
channel/pore that is sensitive to inhibition by TRO196222 and calcium cations. 
4.1.7. Modulation of erythrocyte p50 by acute changes in levels of adenine 
nucleotides.  
Finally, we wanted to gain insight into how are the changes in intracellular 
adenine nucleotide levels as a result of AMP uptake correlated with changes in 
erythrocytes’ oxygen saturation, presented as changes in p50? First we plot the p50 
values against increases in intracellular erythrocytes’ AMP, ADP, and ATP levels 
(Figures 28, 29, 30). There was a clear linear correlation between the rise in 
intracellular AMP and the increase of the erythrocytes’ p50 with an average r2 = 0.96 
among the genotypes (Figure 28). However, there was no apparent correlation 
between the changes in the erythrocytes’ p50 and the intracellular ATP or ADP levels 
(Figure 29 and 30). Given our previous observation that the ATP:ADP ratio was  
76 
 
 
 
 
 
Figure 28. Correlation of p50 shift with intracellular change of AMP as a result of 
AMP incubation. A-D) Plot of p50 change vs. change in intracellular AMP of the four 
genotypes. (A; wild type, B; Ampd3-/-, C; Cd73-/-, and D; Ampd3-/-/Cd73-/-). 
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Figure 29. Correlation of p50 shift with intracellular change of ADP as a result of 
AMP incubation. A-D) Plot of p50 change vs. change in intracellular ADP of the four 
genotypes. (A; wild type, B; Ampd3-/-, C; Cd73-/-, and D; Ampd3-/-/Cd73-/-). 
 
78 
 
 
 
 
 
 
 
Figure 30. Correlation of p50 shift with intracellular change of ATP as a result of 
AMP incubation. A-D) Plot of p50 change vs. change in intracellular ATP of the four 
genotypes. (A; wild type, B; Ampd3-/-, C; Cd73-/-, and D; Ampd3-/-/Cd73-/-). 
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inversely correlated with extracellular AMP levels (Figure 25), the plot of the 
erythrocytes’ p50 against the intracellular ATP:ADP ratio revealed that they are also 
inversely related with an r2 = 0.82  (Figure 31).  
While the direct correlation of p50 with acute intracellular AMP uptake is clear, 
our earlier studies (Fig 10 A and B) showed that AMP’s effect on purified human Hb-A 
p50 is weak. One possibility is that the effect of AMP on erythrocytes’ p50 is indirectly 
mediated by factors or processes absent in the purified human Hb-A preparation. As 
shown in Figure 15D, the p50 increases as a function of AMP concentration was 
comparable in isolated mouse erythrocytes (m= 1.0 +/- 0.2) and lysed erythrocytes (m= 
0.83 +/- 0.01).  
Another possibility for the discrepancy in observations is the species difference 
between human and mouse Hb, as it has been shown that p50 values among 
hemoglobin from different animal species is different (Weber and Campbell, 10). To 
investigate this possibility, we compared the p50 shift of isolated mouse and human 
erythrocytes as a function of extracellular AMP concentration (Figure 32 A). While the 
rate of p50 increase with respect to AMP levels of isolated erythrocytes from mouse 
(m= 1.00 +/- 0.13) and human (m= 0.87 +/- 0.03) was not significantly different, the 
baseline p50 reading for human versus mouse erythrocytes’ p50 is 28 versus 40, 
respectively. These observations suggest that the weak p50 shift induced by AMP 
using purified human Hb-A needed to be further examined. Given that purified mouse 
Hb-A was not available commercially, we chose to examine whether the p50 shift of 
human erythrocytes’ lysate in response to AMP is comparable to purified human Hb-A. 
Using isolated human erythrocytes, which had been freeze-thawed twice at -80°C, we  
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Figure 31. Correlation of p50 shift with intracellular change of ATP:ADP ratio as a 
result of AMP incubation. Correlation of the change in p50 with the ATP:ADP ratio in 
response to AMP incubation.  
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Figure 32. Comparison of human vs. mouse p50 in response to AMP.  A) p50 
values of intact erythrocytes from Mouse and Human in relation to extracellular AMP 
concentrations. B) Comparing p50 values of human erythrocytes, lysed erythrocytes, 
and purified Hb-A in respond to extracellular AMP concentrations. 
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measured the p50 shift induced by AMP as compared to isolated erythrocytes and 
purified human Hb-A (Figure 32 B). Unlike the mouse isolated erythrocytes and lysate, 
where the p50 shift induced by AMP was comparable, the p50 shifts induced by AMP 
were much stronger in intact human erythrocytes than in lysate. The p50 shift induced 
by AMP in the lysate was more than twice that from the purified Hb-A. We surmise that 
the differences in p50 baselines (starting point) among intact erythrocytes, lysates, and 
purified Hb-A could possibly be due to the presence of co-factor(s), that gets diluted in 
the lysate and is absent in purified Hb-A. Known co-factors present in intact 
erythrocytes and crude lysate include 2,3-BPG and ATP that regulate hemoglobin p50. 
However, given that the Hemox-reaction mixture is 4 mL and that the added lysate 
volume is 50 µL, an 80 times dilution, the concentration of these lysate co-factors 
would be in the µM range. Neither 2,3-BPG nor ATP, would have significant effects on 
Hb-A p50 oxygen saturation at such concentration. This raises the question of whether 
another “co-factor” may exists that could have mediated the AMP induced p50 shift in 
the lysate and in intact erythrocytes. 
4.2. Discussion 
The importance of CD73 and AMPD3 in modulating the response of the animal 
to AIHM was evident when comparing the responses from mice deficient in both CD73 
and AMPD3 to those from wild type and the single gene mutant mice. Applying a sub-
optimal dosage of AMP to differentiate the responses from various strains of mice, we 
observed the longest length of torpor was in Ampd3-/-/Cd73-/- mice, then Cd73-/-, 
followed by Ampd3-/- mice. Meanwhile, the wild type mice largely failed to enter torpor 
for any significant length of time under a Ta of 15
°C. These observations were further 
confirmed when the optimal dosage of AMP was administered, when mice of all four 
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genotypes underwent torpor successfully. Here we observed the earliest arousal from 
torpor were wild type mice, followed by Ampd3-/-, then Cd73-/-, and finally Ampd3-/-
/Cd73-/- mice. At 12 h after AMP administration, about 95% of Ampd3-/-/Cd73-/- 
remained in torpor. In contrast, 95% of wild type mice had aroused from torpor. 
Interestingly, loss of CD73 generated a stronger AIHM response than the loss of 
AMPD3, suggesting that extracellular catabolism of AMP by CD73 is a major regulatory 
step in preventing AIHM. The observations that the absence of AMPD3 further 
enhanced the AIHM response suggest that the uptake of AMP and its effect on the 
erythrocyte’s function is fundamental in understanding the mechanistic process of 
AIHM.  
Given that a major function of erythrocytes is oxygen transport to tissues, we 
investigated whether AMP could alter the p50 of intact erythrocytes. To eliminate the 
complication of extracellular dephosphorylation of AMP by CD73, we used Cd73-/- 
erythrocytes for these studies. We observed that incubation of isolated intact 
erythrocytes with 2 mM AMP consistently induced a p50 increase of about 4 mmHg. 
We also observed that adenosine, at a similar concentration, gave p50 values that 
were insignificant to those from PBS or vehicle buffer. The increase in p50 induced by 
AMP was comparable among the erythrocytes from all four genotypes, further 
confirming that dephosphorylation of AMP is not essential for mediating the p50 shift. A 
titration of extracellular AMP concentrations up to 20 mM against erythrocytes’ p50 
value revealed a linear (r2 = 0.99) correlation between these two parameters. Despite a 
large increase in p50 induced by 20 mM extracellular AMP, the Hill coefficient, which 
measures hemoglobin’s co-operative binding of oxygen, remained constant and is 
within its known values of 2.3-3.0 (Perutz, 1970). These observations suggest that the 
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erythrocytes hemoglobin co-operative oxygen binding function were change by being 
expose to non-physiological concentrations of AMP. Thus, it suggests that the 
erythrocytes’ function in oxygen transport inherently has a large capacity to respond to 
extracellular AMP. Observing comparable rates of p50 increase from intact and lysed 
mouse erythrocytes as a function of extracellular AMP concentration, we concluded 
that the effect of AMP on hemoglobin is not mediated via a receptor based mechanism.  
Our previous studies have suggested that AMP can be directly taken up by the 
erythrocytes, though the nature of this uptake process is poorly understood. While 
studying the stability and fate of extracellular AMP in the whole blood of wild type and 
Cd73-/- mice, we observed that AMP was rapidly taken up by both wild type and Cd73-/- 
erythrocytes. The extracellular AMP was also rapidly catabolized by wild type but not 
Cd73-/- whole blood, validating conclusion that CD73 is the major extracellular catabolic 
enzyme for AMP (Castrop et al., 2004). In contrast to the whole blood, incubation of 
AMP with isolated erythrocytes resulted in minimal degradation of AMP, indicating that 
CD73 is not associated with the outer membrane of erythrocytes. As ATP and ADP can 
be dephosphorylated extracellularly by ATPase (CD39) into AMP, we investigated 
whether ADP could also enter intact erythrocytes. Our studies revealed that 
extracellular ADP was rapidly dephosphorylated into AMP within minutes of incubation 
with isolated erythrocytes. The appearance of ADP inside the erythrocytes after about 1 
h of incubation could have been converted from AMP taken up by erythrocytes via the 
adenylate equilibrium. These observations indicate that ADP likely does not enter the 
erythrocytes directly. The rapid conversions of ADP into AMP by the isolated 
erythrocytes suggest that the ATPase is likely associated with the extracellular 
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membrane, which is consistent with studies showing that Mg2+ and Ca2+ dependent 
ATPase have been purified from erythrocytes membrane (Wang and Guidotti, 1996).  
Using radiolabeled AMP, we measured AMP uptake by Cd73-/- erythrocytes 
initially to exclude the possibility of uptake via adenosine. We observed a direct 
correlation between increases of radioactivity in cellular fraction with decreases of 
radioactivity in extracellular supernatant over a 2 h incubation period. In addition, we 
observed a linear (r2 = 0.99) correlation between AMP uptake and extracellular AMP 
concentration from 0.01 to 10 mM suggesting that the uptake rate is driven by an AMP 
concentration gradient across the erythrocyte’s membrane. These observations are 
consistent with the p50 findings where increases in p50 have a linear correlation with 
extracellular AMP concentrations. Examining the AMP uptake in wild type erythrocytes, 
we observed a “saturable” component at about 0.1 – 0.8 mM of extracellular AMP, not 
observed in Cd73-/- erythrocytes. We reasoned that the saturable component is likely 
contributed by adenosine uptake via ENT1 due to residual levels of white blood cells 
that express CD73 in the isolated wild type erythrocytes. To characterize the 
involvement of adenosine in AMP uptake, we examined the effect of dipyridamole, a 
specific blocker of ENT1, on the uptake of AMP by Cd73-/- erythrocytes. We found that 
the erythrocyte uptake of AMP was unaffected by dipyridamole. We were able to 
replicate this result in wild type whole blood, showing that the uptake of AMP was 
unaffected by dipyridamole. These observations indicate that ENT1 is not a transporter 
for AMP uptake, and that the uptake of AMP was not the result of a conversion to 
adenosine entering the erythrocyte via ENT1. Our observation verified a previous 
report that AMP uptake by erythrocytes is unaffected by dipyridamole (Mathews et al., 
05).  
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Among the few membrane proteins that had been shown to be permeable to 
adenine nucleotides, ADP/ATP translocases (ANT) have been characterized for 
mitochondria and peroxisomes (Guitierrez-Aguilar and Baines, 2013). The ANT is 
known to transport ATP out of the mitochondrial matrix in exchange for ADP from the 
inner-membrane space. One study has suggested that isolated ANT was able to 
transport AMP (Fiermonte et al., 2009). Interestingly, an earlier proteomics study 
showed that ANT1 was expressed in reticulocytes, the immature erythrocyte (Prenni et 
al., 2012), while another study suggested the expression of ANT in mature erythrocytes 
(Bouyer et al., 2011). Therefore, we investigated whether similar players were involved 
in AMP uptake of the erythrocytes. Carboxyatractyloside (CAT) was previously shown 
to inhibit ANT nucleotide transport in the mitochondria (Vignais, 1976). We found that 
the AMP uptake by the erythrocytes was not blocked by CAT. These observations 
suggest that the uptake of AMP by erythrocytes is not mediated by an ATP-ADP 
translocase.  
Tannic acid (TAN) is a large molecular inhibitor of various channels and 
transporters including the SLC25 transporter proteins (Guitierrez-Aguilar and Baines, 
2013). Using a dose of 0.2% TAN, we observed a greatly reduced AMP uptake 
compared to control. Even at 0.002% of TAN, we observed a significant reduction in 
AMP uptake by erythrocytes. This inhibitory effect of TAN on the AMP uptake suggests 
that the channel responsible for AMP uptake is either directly inhibited by TAN or that 
the presence of the large molecular TAN complex passively blocks the channel. Given 
the broad target of TAN on many channels and transporters, the identity of the AMP 
channel/transporter remains unclear.   
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  In addition to pharmacological blockers, we further investigated whether there 
were natural nucleotides or metabolites that could modulate the AMP uptake activity, 
presumably through competitive inhibition. We found that common metabolites such as 
glucose, lactate and urea did not inhibit AMP uptake by erythrocytes at the similar 
concentration to extracellular AMP. Nucleosides, such as adenosine, also did not inhibit 
AMP uptake by erythrocytes indicating that the uptake of adenosine and AMP likely 
occurs through separate channels. These observations are consistent with the 
dipyridamole studies described earlier. We observed that the three adenine nucleotides 
and GMP were all able to reduce uptake of AMP by erythrocytes. However, a titration 
of AMP uptake against GMP as an antagonist demonstrates that AMP uptake was not 
significantly altered. In the uptake studies, the inhibition of AMP uptake by ADP and 
ATP is not surprising given that our studies and others have demonstrated the 
presence of ATPase (CD39) associated with the membrane of erythrocytes (Wang and 
Guidotti, 1996). It is possible that the ATP and ADP are rapidly degraded to unlabeled 
AMP, which acts as a competitor to the radiolabeled AMP.  
 As demonstrated in the physiological studies in Chapter 3, the ratios between 
adenine nucleotides in the erythrocytes are maintained by the adenylate equilibrium 
despite differential levels of these nucleotides in the respective genotypes. As 
previously discussed, adenylate kinase maintains a tight regulation of adenine 
nucleotides by facilitating the reversible reaction of AMP + ATP  2ADP. However, 
will the adenylate equilibrium be maintained when erythrocytes are challenged with an 
acute increase of extracellular AMP? Using HPLC, we quantified the adenine 
nucleotide levels in erythrocytes from all the genotypes after AMP incubation. The 
response to extracellular AMP on the intracellular AMP was consistent with the 14C-
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AMP uptake experiments demonstrating a linear correlation with respect to extracellular 
AMP concentration. However, the change of the ADP and ATP levels was not as 
predicted by the adenylate equilibrium. We observed that intracellular ATP did decline 
but not in a linear fashion that matched the uptake of AMP. Rather, the decline 
displayed an inverse exponential profile with respect to extracellular AMP 
concentration. It showed that an initial increase in intracellular AMP resulted in a rapid 
decline in intracellular ATP. However, this decline in ATP then plateaued beyond about 
1 mM extracellular AMP. The other unexpected finding was the intracellular ADP levels 
were relatively constant despite significant changes in intracellular AMP and ATP 
levels. Based on the adenylate equilibrium equation, we would have predicted that ADP 
should increase when ATP decreases and as AMP increases. These observations 
suggest that the adenine nucleotide ratios are not successfully maintained by adenylate 
kinase in response to the rapid influx of AMP, or that the process to restore the 
equilibrium through adenylate kinase requires a much longer time frame for the 
erythrocytes. In addition, there are other enzymes in the erythrocytes such as AMP 
kinase that could be activated by the influx of AMP, or the decrease in ATP may have 
activated other pathways.  
Studies have shown that erythrocytes export ATP as a result of stress signals, 
one of which is low oxygen saturation similar to what we are seeing in our AIHM mice 
(Goldman et al., 2012). The above consideration led us to investigate whether 
erythrocytes’ ATP release can be triggered by uptake of AMP, while using responses to 
other nucleotides and adenosine for comparison. Among the panel of nucleotides and 
nucleosides tested, including 5’-CMP, 5’-GMP, 5’-3’-cAMP, 5’-IMP, adenosine and 5’-
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AMP, only 5’-AMP consistently induces ATP release from the erythrocytes. Addition of 
3’-AMP could also result in a release of ATP slightly greater than the saline control.  
In efforts to find out the possible transporter for ATP release, we tested if TAN 
would also inhibit the erythrocyte ATP release, knowing that AMP uptake can be 
inhibited by TAN. A strong decline in ATP release was observed following the addition 
of the TAN, but the result was compromised by the observation that TAN was inhibitory 
on the luciferase reaction, even at low doses. Another study reported that ATP 
released by erythrocytes was mediated by PANX1 and that a PANX1 specific inhibitor, 
carbenoxolone (CBX), could block ATP release by erythrocytes (Goldman et al., 2012). 
However, we observed that CBX did not prevent AMP induced ATP released by the 
erythrocytes. In addition, we also observed that CBX did not alter the AMP induced p50 
increase in isolated erythrocytes. Thus, PANX1 is likely not involved in ATP release 
induced by AMP uptake. Other studies have reported that the voltage dependent anion 
changer (VDAC) is known to exchange ATP for ADP in the inner mitochondrial 
membrane and it has been suggested a similar protein is on the membrane of the 
erythrocytes (Sridharan et al., 2012). We found that TRO19622, a VDAC inhibitor, was 
effective in partially inhibiting the ATP release that was induced by extracellular AMP. 
This finding suggests that a VDAC type protein might be responsible for this ATP 
release induced by AMP. However the inhibition level by TRO19622 was about 30% of 
the control values, suggesting that other channels/pore could also be involved.  
These observations led us to investigate the properties of VDAC. VDAC is 
known to be inhibited by Ca2+, having divalent cation binding sites on the external 
interface of the protein (Shoshan-Barmatz et al., 2010). Since TRO19622 inhibition 
implicated VDAC as a potential transporter for the ATP release, we investigated 
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whether divalents, namely Mg2+ and Ca2+, were able to inhibit the ATP release. Mg2+ 
was unable to impact the ATP release when added to the buffer, however, Ca2+ was 
able to inhibit ATP release significantly. By measuring ATP release against a titration of 
Ca2+ concentrations, we found that the maximal inhibition occurred around 100 μM, 
with an IC50 of ~10 μM. These data suggest that a voltage dependent channel could be 
responsible for releasing ATP that is induced by AMP uptake by erythrocytes.  
Evidence from our studies further suggests that erythrocytes, which do not have 
de novo purine biosynthesis, regulate their intracellular adenine nucleotide levels via its 
ability to uptake AMP and released ATP. The ATP released by erythrocytes into the 
extracellular matrix has been reported to be triggered by stress signals such as hypoxia 
and exercise (Goldman et al., 2012). It has been shown that extracellular ATP has 
important biological functions, such as activating the P2Y family of receptors which help 
control vascular tissue relaxation and blood pressure (Ellsworth et al., 2009). We 
surmised that the extracellular enzymes, such as CD73 and ATPase/CD39, are part of 
the regulatory control on the movement of adenine nucleotides into the erythrocytes. 
While releasing energy to drive various cellular activities, ATP and ADP undergo 
dephosphorylation by erythrocyte-associated ATPase to AMP. The AMP, in turn, is 
either taken up by erythrocytes, which then moderates Hb p50 values in modulating 
tissue oxygen consumption. Alternatively, the AMP could be dephosphorylated 
extracellularly by CD73 into adenosine that could be utilized by adenosine receptors, 
while the excess adenosine is rapidly degraded by adenosine deaminase. Hence, our 
studies would suggest that the erythrocytes, which utilize glycolysis as an ATP 
regenerator, are a power source for extracellular matrix function, a somewhat parallel 
role to the mitochondria in intracellular function of nucleated cells. 
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 Having demonstrated that the intracellular AMP levels correlate linearly to 
extracellular AMP uptake, it is not surprising to see that there is a direct positive 
correlation of p50 increase with intracellular AMP, but not ATP or ADP concentrations. 
A linear correlation between increases in intracellular AMP and p50 has an r2 of ~0.96, 
which is close to a perfect correlation value of 1.0. In contrast, those of ADP and ATP 
concentrations against p50 increases had r2 of ~0.5 and ~0.4, respectively.  
Having observed an inverse linear shift in ATP:ADP ratio corresponding to 
extracellular AMP concentrations, we examined the correlation between ATP:ADP ratio 
and the p50 increase. An inverse correlation between ATP:ADP and p50 shift present 
itself with an r2 value of about 0.82, suggesting that ATP:ADP ratio and p50 increased 
are likely linked. This inverse correlation between the ATP:ADP ratio with p50 values 
was observed in erythrocytes from all genotypes indicating that the differential in 
adenine nucleotides levels between AMPD3 deficient and proficient cells did not alter 
this correlation. In contrast, the ATP:AMP ratio had no correlation to the p50 values. 
Together, these observations suggest that the p50 increase could be a result of either 
the increasing intracellular AMP levels or is mediated indirectly via pathways controlled 
by AMP dependent enzymes such as AMPK. Alternatively, the possibility of enzymatic 
pathways modulating Hb oxygen saturation being activated or inhibited after sensing 
the change in the ATP:ADP ratio cannot be excluded. The exact mechanism of how 
non-physiological AMP modulates p50 increases remains to be addressed.  
Our observation that AMP has a weak effect on purified human hemoglobin (Hb-
A) p50 suggests several possibilities. One possibility is that mouse and human 
hemoglobin may have different responses to AMP. To address this possibility, we 
compared p50 values in intact isolated erythrocytes from human and mouse blood in 
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response to AMP. We found that the human erythrocytes similarly experience an AMP-
induced p50 shift to the mouse erythrocytes. The rate of p50 increase with respect to 
extracellular AMP concentration gave slopes (m value) of 0.87 and 1, for human and 
mouse, respectively. Next we compared mouse intact erythrocytes and their lysed 
counterpart in p50 shift as a function of AMP concentration. We observed comparable 
rates of p50 increases as a function of AMP concentration for mouse erythrocytes and 
their lysates with slopes of 1.0 and 0.84, respectively. However, when we compared 
intact human erythrocytes to lysed human erythrocytes and purified Hb-A, we observed 
a great differential with the rate of change from intact erythrocytes (m=0.87) giving the 
biggest rate of change in p50 compared to lysed erythrocytes (m=0.47) and purified 
Hb-A (m=0.23) in response to AMP. To provide a rationale for these observations, we 
reasoned that modulators of Hb-A oxygen saturation were present in the intact 
erythrocytes that were diluted in the lysate but were absent in the purified Hb-A. Given 
that the lysates were diluted approximately 100 fold in the lysate studies, the 
observation will rule out common modulators of p50 such as 2,3-BPG and ATP. The 
possibility of novel co-factors that could modulate AMP effects on Hb p50 cannot be 
ruled out.  
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5. Summary 
In order to further our understanding of the role of adenine nucleotides in 
erythrocyte function, we created a mouse model that was deficient in both AMPD3 and 
CD73, the key intracellular and extracellular AMP catabolic enzymes, respectively. The 
current studies demonstrate that this enzymatic deficiency significantly alters the 
physiological (steady state) regulation in erythrocytes’ function and enhances the 
animals’ sensitivity to AIHM, without altering the mechanism of how erythrocytes 
respond to acute changes in extracellular AMP levels.  
Our investigations on the physiological impact of the double deficiency suggest 
that regulation of erythrocytes’ affinity for oxygen could regulate systemic metabolism. 
We show that increased adenine nucleotide levels, ATP in particular, correlate with 
increases in erythrocyte p50 values. We demonstrate using purified Hb in vitro that 
physiological ATP and ADP concentrations can directly modulate Hb p50 at a value 
consistent with observed erythrocyte p50 values in vivo. A rise in the ATP 
concentration leads to increased Hb p50 values and to erythrocytes’ reduced affinity for 
oxygen. Such a decrease in affinity results in release of oxygen at a faster rate to 
working muscle and other tissues, accounting for the enhanced metabolism observed 
in Ampd3-/-/Cd73-/- mice during wheel running. 
The observations from the studies on how erythrocytes respond to non-
physiological extracellular AMP levels suggest that, while erythrocytes readily take up 
AMP, it releases ATP in a process of re-establishing a new balance among AMP, ADP 
and ATP. Our findings suggest that erythrocytes have a previously uncharacterized 
capability of regulating their own adenylate pool, and an extracellular supply of adenine 
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nucleotide and nucleoside by uptake extracellular AMP and release ATP. These 
observations bring new insight that the lack of de novo purine biosynthesis and the 
absence of IMP salvage in erythrocytes could be compensated by the adenine 
nucleotide uptake and release mechanisms. We also found that acute changes in 
intracellular AMP levels lead to a linear decrease in the ATP:ADP ratio, and a linear 
increase (right shifts) in erythrocyte p50 values. Thus, changes in extracellular AMP 
directly regulate erythrocyte p50 and consequently their oxygen transport function. 
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6. Future directions  
 Our investigations lead to new understandings of the role of adenine nucleotides 
in erythrocyte function and regulation, while raising additional questions to be 
answered. First, is AMP uptake mediated by the same channel/transporter(s) 
responsible for ATP efflux? What are the identities of the associated transporters? One 
of the first transporters that calls for further investigation is VDAC. Our preliminary 
studies showed that a VDAC inhibitor partially inhibited ATP release; whether it also 
blocks AMP uptake has not been tested. VDAC has been shown to be non-selective in 
what it transports (Shoshan-Barmatz et al., 2010). Since VDAC is a gated pore instead 
of a selective channel, it is possible that AMP and ATP could both be using the same 
pore to pass through the membrane. Therefore, we plan on testing both of the VDAC 
inhibitors that showed an effect on inhibiting ATP release, TRO19622 and Ca2+, on 
their effects of AMP uptake and shifting the p50 value of the erythrocytes. Another 
observation that may aid our future studies is the fact that TAN inhibits AMP uptake at 
low concentration. Currently, there is no report of TAN directly inhibiting VDAC. 
However, as mentioned above, TAN could be a steric hindrance to pores due to the 
size of the molecule as opposed to a direct interaction.  
Considering VDAC inhibitor could only block the ATP release partially, additional 
untested transporters that are expressed in erythrocytes will be evaluated. The 
selected transporters will be studied for their possible involvement in AMP uptake 
and/or ATP release by erythrocytes.  
 Another important question pertains to the response mechanism of hemoglobin 
and erythrocytes to AMP. Studies from decades ago show contrasting data; some 
96 
 
reported that hemoglobin responds to AMP while others do not. We observed that the 
difference seems to lie in whether the experiments were done with purified hemoglobin 
or erythrocyte cell lysate. In our own experiments, the p50 of purified hemoglobin was 
weakly responsive to changes in AMP levels. However, we observed a similar p50 shift 
to AMP in erythrocyte lysate to that in erythrocytes. This observation suggests that 
there is(are) endogenous “modulator(s)”, no longer present with the purified Hb, that 
interact with Hb in the erythrocytes and allow Hb to be responsive to AMP. To test the 
assumption that the modifier is a heat-stable metabolite and not a protein, we plan to 
examine if the p50 of purified human Hb can be shifted by AMP upon addition of boiled 
human erythrocyte lysate. Further, to examine if the modifier is a protein, we plan on 
homing in on the protein, initially by sized fractions of the lysate, and then testing 
candidate proteins in the positive fraction.  
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